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ABSTRACT
SARAH HENRY LANDIS: A longitudinal ultrasound study of fetal growth and intrauterine
growth restriction in Kinshasa, Democratic Republic of Congo
(Under the direction of Steven Meshnick)
Each year, 24% of births in resource poor countries are small-for-gestational age (SGA).
Most SGA infants suffer from intrauterine growth restriction (IUGR); a pathologic process
characterized by insufficient transfer of nutrients and oxygen to the fetus and impaired fetal
growth. In resource poor countries, IUGR is frequently due to malaria or maternal under-
nutrition. This dissertation addresses clinically important questions concerning the
pathogenesis of malaria infection in utero and the identification of IUGR in resource poor
settings.
The data source is a prospective, longitudinal ultrasound study of 182 pregnant women
conducted in Kinshasa, Democratic Republic of Congo between May 2005 and May 2006.
Women participated in monthly follow-up visits during which malaria, maternal
anthropometrics, and ultrasound estimated fetal weight (EFW) were measured.
We estimated the effect of malaria on the risk of IUGR, and assessed whether maternal
under-nutrition modified this relationship. Data from 178 women and 758 ultrasounds were
included. IUGR was defined as EFW below the 10th percentile of a standardized fetal weight
nomogram. Log-binomial models using generalized estimating equations were fitted
separately for malaria and maternal anthropometric exposures and including a product
interaction term between them. A single incident malaria infection was not significantly
associated with IUGR (Risk ratio (RR)=1.2, 95% confidence interval (CI): 0.7, 2.2); women
with 3 episodes were at increased risk (RR=2.3, 95% CI: 0.8, 6.3). The effect of malaria
was significantly stronger among under-nourished women. Prompt treatment of antenatal
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malaria infections may prevent IUGR, especially in under-nourished women.
We developed a fetal size nomogram for Congo using data from 144 women with certain
gestational dates and 755 ultrasound scans. A linear mixed effect model was fitted for EFW
as a function of gestational age that incorporated random effects for the intercept and slope.
Reference intervals were derived from this model and compared with intervals derived from
industrialized countries. The 50th centile EFW for Congo fetuses was consistently lower than
fetuses born in industrialized populations. Comparison of the outer centiles showed
inconsistent patterns, owing primarily to differing statistical techniques. This fetal size
nomogram should improve diagnosis of IUGR in resource poor settings with endemic
malaria.
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CHAPTER 1.
BACKGROUND AND SIGNIFICANCE
Each year, 24% of births in resource poor countries are small-for-gestational age (SGA).1
Most SGA infants suffer from intrauterine growth restriction (IUGR); a pathologic process
characterized by insufficient transfer of nutrients and oxygen to the fetus and impaired fetal
growth. In resource poor countries, IUGR is frequently due to malaria or maternal under-
nutrition.2 The specific aims of this dissertation address two clinically important questions
concerning the pathogenesis of malaria infection in utero and the identification of IUGR in
resource poor settings.
Specific Aim 1: Describe the association between maternal malaria infection and
intrauterine growth restriction in Kinshasa, Democratic Republic of Congo and
determine if maternal nutritional status modifies this relationship.
Specific Aim 2: Utilize prospectively collected ultrasound data to develop a fetal size
for gestational age nomogram for a resource poor population with high malaria
prevalence.
Overview of intrauterine growth restriction
Overview: Normal fetal growth and development can be divided into three physiologic
stages: i) cell replication and proliferation, also know as the hyperplastic phase; ii) cell
migration and aggregation to form tissue and rudimentary organs; and iii) increase in cell
size and formation of functional organ structures, also known as the hypertrophic phase.3
Thus in early pregnancy, very high mitotic activity (DNA replication) is paired with very little
change in mass, while in late pregnancy; mitosis slows with a coincident rapid gain in weight.
As a result, genetic factors most influence fetal growth during the first half of pregnancy, and
hormonal or environmental factors dominate later in pregnancy.4
In a healthy pregnancy, fetuses normally gain about 5 grams per day from 14-15 weeks,
210 grams per day by 20 weeks, and 30-35 grams per day from 32-36 weeks. During the last
month of pregnancy, the growth rate decreases and then levels off around the 40th week of
gestation.5
The placenta plays a key role in fetal growth. During normal placental formation,
trophoblasts from the fetus invade the uterine endometrial lining and obliterate the muscular
walls of the uterine spiral arteries. The spiral arteries convert to maximally dilated
uteroplacental arteries allowing development of a high volume, low resistance circulation.6
During the second and third trimesters, there is also a proliferation in the number of villi and
small vessels in the placental vascular bed. As the number of vessels increases, placental
vascular resistance decreases and blood flow volume through the umbilical artery
increases.7 This increase in blood flow volume through the uterine and umbilical arteries is
necessary to meet the increasing nutritional demands of the rapidly-growing fetus in late
pregnancy.6 Pathophysiological processes that inhibit trophoblastic invasion, obstruct blood
flow, or decrease the number of umbilical tertiary villious arteries and arteriols may result in
decreased delivery of oxygen and nutrients to and from the fetus.8 This, in turn, will likely
impair fetal growth.9,10,11,12,13,14
Impaired fetal growth manifests as decreased fetal body mass and infant low birth weight
(LBW, defined as birth weight less than 2500 grams).15 A diagnosis of LBW indicates three
possible fetal conditions, one of which is normal and two that are pathologic in nature. The
normal condition refers to an infant that is constitutionally (or genetically) small and otherwise
healthy. The pathologic conditions are preterm delivery (PTD) or delivery before 37
completed weeks of gestation, and small for gestational age (SGA) or low attained birth
weight for a given gestational age at delivery. Most SGA infants suffer from intrauterine
growth restriction (IUGR) which occurs when there is sub-optimal transfer of nutrients and
oxygen to the fetus in utero resulting in impaired growth of fetal organs and tissues.
Risk factors for IUGR: Risk factors associated with IUGR can be categorized into three
3broad groups: fetal factors, maternal factors, and uteroplacental factors.
Fetal factors: Fetal causes of IUGR include chromosomal disorders such as trisomy 13,
18 and 21, viral infections such as rubella, toxoplasmosis or cytomegalovirus, multiple
pregnancy, fetal gender and birth order. Chromosomal abnormalities and congenital
malformations are estimated to be responsible for approximately 20% of IUGR while
infections are estimated to account for 5-10% of all IUGR cases.16
Maternal factors: Maternal factors often lead to IUGR through pathways that result in
decreased oxygen-carrying capacity secondary to maternal vascular disease (i.e., diabetes,
hypertension, or renal disease) or placental damage resulting from maternal disease or
environmental exposure (i.e., smoking/drugs, thrombophilia, various autoimmune diseases
or malaria).17 Maternal vascular disease is estimated to account for 25-30% of all IUGR.16
Maternal under-nutrition and micronutrient deficiency may also lead to IUGR if the availability
of substrates for fetal growth is deprived.15
Uteroplacental factors: Uteroplacental factors may manifest as abnormal placental size,
morphology or function. When IUGR is caused by placental abnormalities, the growth
aberration is usually the consequence of decreased delivery of nutritional substrates or
oxygen to the fetus. Small placental size, placental previa, and pathologic features such as
placental abruption, circumvallate placenta, chorioangioma and vaginal bleeding of unknown
etiology have been associated with IUGR.16,18,19
Types of IUGR: IUGR is often categorized as being symmetrical or asymmetrical, although
growth restriction can fall anywhere on a spectrum between these two extremes.20
Symmetrical growth restriction accounts for about 10% of all IUGR and is characterized by
smaller growth than expected of all fetal biometry, showing equally poor growth of the head,
abdomen and short and long bones. Alternatively, asymmetrical growth describes infants
whose body weight is low, with relative preservation of the head, which is close to or being
normally sized. This is thought to be due to the brain-sparing effect that results when the
4fetus is challenged with decreased nutritional reserves, and redistributes blood flow to the
brain, heart, adrenals, and placenta, resulting in diminished relative flow to the bone marrow,
muscles, soft tissue and liver.
The pattern of growth inhibition often depends on the timing of the insult.16 Insults that
occur early in pregnancy or that result in an overall reduction of cellular hyperplasia such as
a genetic abnormality, teratogen exposure (i.e., tobacco, alcohol, drugs) or early viral
infection, are more associated with symmetrical IUGR. Conversely, factors that arise later in
pregnancy (i.e., maternal vascular disease or gestational diabetes) result in uteroplacental
insufficiency and affect fat deposition and the size and protein content of the cells. This
results in brain sparing and an asymmetrical growth pattern.
Perinatal and neonatal complications of IUGR: IUGR fetuses have higher rates of
perinatal morbidity and mortality and are at increased risk of sudden infant death syndrome
and stillbirth. In the early neonatal period, IUGR infants are at increased risk of
hypoglycemia, hypocalcemia, thrombocytopenia, temperature instability, and renal failure2,21
and during childhood, they are more likely to have poor cognitive development and
neurological impairment.22
Identification of intrauterine growth restriction: In the early 1960’s Lubchenco and
colleagues demonstrated an increased risk of perinatal mortality among infants that were
less than the 10th percentile of birth weight for their gestational age.23 Further, the risk of both
perinatal mortality and morbidity increases rapidly as birth weight for age falls from the 10th to
the 1st percentile. These findings served as a foundation for the techniques used today to
characterize fetuses as IUGR. The most commonly used method is to compare either a
single fetal biometric indicator, or estimated fetal weight (EFW), against a standardized fetal
weight-for-gestational age nomogram.
Individual biometric measurements are less commonly used and the sensitivity of a single
measurement to diagnosis IUGR is generally lower than using EFW. Of the single biometric
5measurements, abdominal circumference (AC) has the best correlation with IUGR.24 AC
reflects hepatic size and disposition of subcutaneous fat, both of which are diminished in the
growth restricted fetus. Sensitivity estimates for a cutoff of AC below the 25th centile are 83-
86%, specificity ranges from 79-80%.25 The sensitivity of this measure can be improved to
over 95% if a 2.5% centile is used.26 Utilization of biparietal diameter (BPD) alone is not
recommended as these measurements correlate poorly with IUGR; sensitivity estimates for
BPD range from 43.8% to 100% with most values between 50% and 60%.25 BPD can be
challenging to measure due to factors including fetal lie and variation in fetal head shape.
Head circumference (HC) gives slightly better positive predictive value than BPD alone as it
is not influenced as much fetal head shape. Femur length (FL) alone is also not
recommended because femur growth is affected early in symmetrical growth restriction but
late in asymmetrical IUGR.
Algorithms that combine HC, BPD, AC and FL to calculate EFW in grams are the most
accurate predictors of IUGR and birth weight.27 IUGR assessment using estimated fetal
weight has been found to be accurate to within 10% of fetal weight in about 90% of
pregnancies.24 A cutoff of estimated fetal weight <10th percentile for a standardized
nomogram has been shown to have a sensitivity in the range of 87%-90%, with specificities
of 80%-87%.25
Specific Aim 1: Describe the association between maternal malaria infection and intrauterine
growth restriction in Kinshasa, Democratic Republic of Congo and determine if maternal
nutritional status modifies this relationship
Rationale: In areas of stable malaria transmission, non-pregnant adults have developed a
sufficient level of acquired immunity such that P. falciparum infection does not often result in
fever or other clinical symptoms. However, pregnant women are more susceptible to malaria
infection and its disease consequences, especially in their first and second pregnancies. A
review by Steketee of 34 studies of malaria infection, adverse pregnancy outcomes and
6pregnancy associated conditions (such as anemia) showed that P. falciparum malaria in
pregnancy consistently contributed to LBW through both PTD and IUGR.28 Nine studies
reported risk ratios for LBW ranging from 1.4 to 1.8, with population attributable risks of 8 to
14%. Five studies reported results separately for preterm-LBW and IUGR-LBW. In these
studies, maternal malaria infection accounted for approximately 8 to 36% of preterm-LBW
and 13-70% for IUGR-LBW. Malaria is also a major cause of anemia in sub-Saharan Africa
which is independently a risk factor for LBW.29,30
In the developing world, it has long been recognized that childhood malnutrition and its
sequelae influences susceptibility to malaria infection and can influence the severity of
malaria associated morbidity and mortality.31-33 Repercussions of childhood malnutrition and
malaria infection, such as stunting and low young adult BMI place reproductive age women
at increased risk of poor birth outcome. In women who have become pregnant, the joint
effects of these conditions may act on similar physiologic pathways to reduce uteroplacental
blood flow. Further, these conditions both contribute to maternal anemia, which
independently contributes to LBW through decreased maternal-fetal oxygen transfer.34,35
Thus, in pregnant women, it is likely that maternal nutritional status will modify the
relationship between malaria and fetal growth.
Biologic mechanisms linking malaria to poor birth outcome: The unique relationship
between malaria infection and pregnancy results from the inability of pregnant women to
mount an adequate immune response against P. falciparum parasites. The malaria parasite
life cycle has multiple stages occurring in both the human host and mosquito vector.36
Malaria illness occurs during the erythrocytic stage, when the merozoite form of the parasite
invades a red blood cell, matures, and ruptures the red cell, releasing multiple daughter
merozoites who then repeat this cycle. During P. falciparum parasite maturation, variant
surface antigens (VSAs) are expressed on the surface of infected red blood cells (IRBC).
These VSAs bind to endothelial cell receptors and allow the IRBC to sequester in the
7vascular bed of various tissues. Sequestration allows the parasite to avoid the immune
system’s surveillance, thus facilitating parasite replication and progression to symptoms.37 In
non-pregnant adults, IRBCs express erythrocyte membrane protein 1 (PfEMP1) antigens
that binds to the placental glycoprotein CD-36 receptor. However, in pregnant women, a new
subpopulation of parasites arise that express different PfEMP1 antigens with distinct binding
phenotypes, uniformly binding chondroitin sulphate A (CSA) on the surface of the placenta
(and not CD-36)37,38 (Figure 1.1).
During a first pregnancy, women posses antibody titers against common PfEMP1.
However there is an absence of antibodies to the subpopulation that binds to CSA.39,37 Since
the primigravid immune system has never “seen” this antigen before, there is no pre-existing
immunity and thus primigravida have higher density malarial infections. Conversely,
antibodies that block parasite adhesion to CSA are found in sera from multigravida. Thus,
multigravid women have acquired antibodies that can limit parasite sequestration in the
placenta and provide some protection from placental infections. This pattern suggests that
antibodies to the CSA binding PfEMP1 antigen develop only over successive pregnancies,
accounting for the increased susceptibility of primigravida and secundigravida to infection.
This also explains in part why pregnant women have more frequent and higher density
infections than non-pregnant women.
After IRBC cytoadherence to the placental surface has taken place, uteroplacental
function and fetal growth can be affected through a variety of mechanisms (Figure 1.1). First,
malaria infections (and the immune response to them) early in pregnancy (<20 weeks) might
affect uterine artery blood flow by impairing the process of trophoblast invasion and
uteroplacental vascular and arterial development, as occurs in preeclampsia.40 This would
result in decreased placental vascularization and uteroplacental circulation, rendering the
placenta unable to meet the fetal metabolic demands of late pregnancy.17,41
8Figure 1.1. Biologic mechanisms linking malaria infection to low birth weight
The next two mechanism center around the pregnant host’s impaired immune response to
placental malaria infection. Because pregnant women do not posses antibody titers against
the subpopulation of VSAs that binds to CSA, parasites are able to sequester in the
intervillious spaces of the placenta which may alter the dynamics of the maternal-fetal
exchange.42,43 As large numbers of parasites and macrophages accumulate in the
intervillious space, a nearly solid mass of reticuloendothelial cells is formed. As well, P.
falciparum-infected placentas show a thickening of the basement membrane of placental
trophoblast cells.42 Both the large mass of reticuloendothelial cells and the thickening of the
basement membrane can inhibit growth and vascularization of the placenta, leading to
decreased transplacental nutrient and gas transport and/or fetal hypoxia.
The second mechanism involves a Type 1 and Type 2 immune system imbalance. The
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9Type 1 arm of the human immune system (also called the cellular or pro-inflammatory
response) is the major host response against intracellular pathogens like malaria. The Type
2 response (also called the humoral or anti-inflammatory response) is the major host
response against extracellular pathogens such as bacteria and helminthes. Cytokines that
stimulate Type 1 tend to inhibit Type 2, and vice versa and thus, the immune response is
often biased either toward Type 1 or Type 2. Wegman and colleagues proposed that a
normal healthy pregnancy requires the inhibition of the Type 1 response to prevent a woman
from mounting an immune response against fetal tissue.44 Malaria infections during
pregnancy induce proinflammatory Type 1 cytokines, such as TNF-, IFN- and other
cytokines in the IFN- pathway like IL-12.41,45,46 This increase in Type 1 cytokines may
accompany inflammatory cell infiltration into the placenta. Monocytes also produce TNF45
and chemokines that attract further monocytes into the intervillious space.47 These data
suggest that it may be the inflammation and not that actual infection that is a proximal cause
of poor pregnancy outcome. Placental levels of cytokines have been repeatedly associated
with lower birth weight.45,48,49
The final mechanism relates to malaria’s effect on maternal anemia. Malaria causes
maternal anemia through a combination of dyserythropoesis (inability to make new red blood
cells) and destruction of infected and uninfected erythrocytes.34 Anemia might contribute to
placental hypoxia, and to impaired placental growth and vascularization. Moderate or severe
anemia is a recognized independent cause of LBW.35
HIV and malaria co-infection in pregnancy: Human immunodeficiency virus (HIV) has
emerged as a major public health problem in areas of sub-Saharan Africa with endemic P.
falciparum malaria. Due to the high prevalence of both diseases in sub-Saharan Africa, co-
infections are common. The ability of HIV to reduce the host immune response to other
infectious agents exacerbates the adverse maternal health effects of malaria during
pregnancy.
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HIV-positive women appear to be particularly vulnerable to malaria infection,50 and co-
infected women have a higher risk of malaria associated SGA.51,52,53,54 HIV may increase
susceptibility to malaria by exerting effects on humoral 55 and cellular immunity,41,56 thus
impairing development of antibodies to malaria at all gravidities. The greatest impairment is
in recognition of parasites that express placenta specific VSAs.55 Women who are most
immunosuppressed (lowest CD4 cell counts) have the least antibodies to these VSAs. Due
to this impaired immunity, HIV-infected women have a higher prevalence and density of both
peripheral and placental parasitemia compared to HIV negative women.57,58,59,60 This
increase is seen among both multigravida and primigravida, suggesting a shift in the burden
of high parasitemic malaria from primarily primi- and secundigravida to all pregnant women
and altering the well established gravidity specific pattern of malaria susceptibility.
HIV may also worsen malaria effects through anemia; HIV and malaria co-infected women
are at greater risk of anemia, possibly due to a larger parasite burden and longer duration of
malaria infection in HIV positive women.50
Biologic mechanisms linking maternal nutritional status to IUGR: During pregnancy,
unique maternal metabolic and physiologic processes occur to meet increasing energy
demands related to fetal development.61 An additional energy demand of 200 to 300 kcal per
day above non-pregnant energy needs is required to support growth of the fetus, placenta
and maternal tissues.62 Women with nutritional deficiencies are often unable to meet this
increased demand. Within the context of pregnancy, nutritional deficiencies often take on
one of two distinct forms: (i) under-nourished at the time a woman becomes pregnant; and (ii)
inability to meet or sustain adequate protein or caloric intake during the antenatal period. In
both the developed and developing world, maternal nutritional status before and during
pregnancy is a well-recognized determinant of infant birth size.63
Chronic under-nutrition and acute episodes of low food intake render the mother
incapable of meeting the increasing metabolic demands of pregnancy through a variety of
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physiologic pathways. In a healthy pregnancy, plasma volume begins to increase near the
end of the first trimester and increases by greater than 50% by 34 weeks gestation.64 This
expansion is necessary to sustain the elevated cardiac output required to supply blood to
maternal tissues and organs. Inadequate energy or protein intake prevents adequate
plasma volume expansion limiting maternal cardiac output and blood perfusion to the
placenta and uterus.65,66,67 Inadequate plasma volume expansion is associated with poor
obstetrical outcomes including spontaneous abortion, stillbirth and SGA.64,66
In a second pathway, acute episodes of starvation during gestation result in a reduction
in plasma glucose levels which can induce changes in the normal transfer of nutrients from
mother to fetus.67 Coincident with decreased plasma glucose, the mother will reserve amino
acids to be utilized by her own liver for gluconeogenesis, thus decreasing the transfer of
several essential amino acids to the fetus. Further, fetal insulin levels will decrease to
compensate for reduced availability of glucose, which influences fetal fat deposition and
protein synthesis.
A final pathway involves maternal body fat composition and fat deposition. In a healthy
pregnancy, woman lay down subcutaneous fat stores as a maternal energy reserve and to
support the rapid growth of the fetus during the latter part of pregnancy.68 Inadequate
energy intake can affect both a woman’s baseline body composition and her ability to
accumulate adequate fat stores to sustain fetal demand.8,69
Anthropometric indicators of maternal nutritional status: Maternal nutritional status is often
measured using anthropometric indicators collected before and longitudinally during
pregnancy.70 Commonly used indicators include: 1) pre-pregnancy weight and body mass
index (BMI), 2) maternal height, 3) pregnancy weight gain, and 4) mid upper arm
circumference (MUAC). Maternal anthropometric indicators have been demonstrated to be
better predictors of pregnancy outcome than measures of dietary intake.71
The sections below provide detailed information about each indicator including a
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discussion of the physiologic basis for the indicator, reported epidemiologic associations
between the indicator and poor birth outcomes including SGA and LBW, and proposed cutoff
values for monitoring nutritional status.
Maternal height: In the developing world, reduced maternal stature is often a
consequence of chronic under-nutrition in early childhood.33,67 Height has been used to
predict neonatal outcomes and to identify women at greatest risk of obstetrical complications
including prolonged or obstructed labor, cephalopelvic disproportion, or cesarean section.72
The use of height as a predictor of poor fetal growth needs to be interpreted with caution
however, as height is often highly correlated with other maternal anthropometric indicators.
For example, taller women are generally heavier but have lower BMI measures than shorter
women; so any effect of height may be secondary to, or confounded by, maternal weight or
muscle and fat reserves.70
In general, taller women appear have higher birth weight infants than smaller
women.73,74,75,76,77,78 Studies in resource poor settings have found an effect of maternal height
in the range of 10-22 grams per centimeter increase in height.70 Women who are shorter
also appear to be a significantly increased risk of delivering a LBW79,80 or SGA81 infant.
However, two studies in resource poor settings (Senegal and Peru) showed no effect of
height on birth weight after controlling for maternal muscle or fat reserves82,83 and studies
from the US and Sweden showed that a height effect was attenuated after adjustment for
maternal pre-pregnancy weight.76,84 Naeye and Tafari found that height affected birth length,
but not birth weight, in a study of pregnant Ethiopian women.85
Height is a highly desirable anthropometric indicator to utilize in pregnancy studies in
resource poor settings as it is fairly easy to measure and can be recorded at any time during
the pregnancy. Several potential cut-offs values ranging from 140 to 150 cm have been
explored as indicators of LBW in resource poor settings.70,86
Maternal pre-pregnancy weight/body mass index (BMI): Body fat is often estimated
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using a formula that incorporates weight and height, most commonly the body mass index
(BMI=weight in cm/height in m2), under the assumption that most of the variation in weight is
due to fat and not lean body mass. BMI is strongly correlated with fat mass measured by
Dual-energy-x-ray absorptionometry.87 Low maternal pre-pregnancy weight and BMI are
considered markers for minimal nutrient reserves. Further, as plasma volume is highly
correlated with body weight, low pre-pregnancy weight or BMI may play a role in insufficient
plasma volume expansion early in pregnancy.65 In general, women in resource poor
countries have lower pre-pregnancy weight and BMI than women in industrialized
countries,88 and low pre-pregnancy weight is often associated with poor weight gain during
pregnancy.70
In both industrialized and resource poor countries, women with low pre-pregnancy weight
or BMI have consistently delivered lower birth weight babies.76,89 In a study of indigent
women from the southern United States, Neggers and colleagues demonstrated a nearly
300 gram increase in absolute birth weight comparing women in the 90th percentile of pre-
pregnancy weight to women in the 10th percentile and concluded that pre-pregnancy weight
was the best predictor of infant birth weight.74
Maternal pre-pregnancy weight and BMI status have substantial effects on the risk of LBW
and SGA. A study of over 20,000 infants in the United States showed a decrease in the
percent of infants born LBW with increasing pre-pregnancy weight.90 An investigation of risk
factors for LBW showed that nearly 60% of infants born <2,500 grams were born to women
weighing less than 50.8kg; short women with low pre-pregnancy weight had the highest rate
of LBW.80 In a large prospective study of predominantly black indigent women in the United
States, there was a 3-fold increase in SGA risk among women with low pre-pregnancy
weight after adjustments were made for other confounders.81 A study in India found a similar
magnitude of effect for women weighing less than 40kg prior to pregnancy and showed that
pre-pregnancy weight was the strongest predictor of SGA in bivariate and multivariate
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analyses.91
Using data from 46 national surveys of mothers aged 15–49 from 36 resource poor
countries, Nestel and Rutstein defined de facto reference BMI cutoffs for pregnant women.92
Four reproductive outcomes were compared according to BMI categories: neonatal and
infant mortality, size at birth, birth weight, and miscarriage or stillbirth. Women with low BMI
had babies that were smaller and of lower birth weight than women with normal or high BMI;
neonatal and infant mortality rates were also highest in the lowest BMI group. Studies from
New Guinea and Jamaica confirm these findings.77,78
In resource poor settings where women often initiate prenatal care in the second trimester,
a major challenge to implementing this indicator is the lack of an estimate of “true” pre-
pregnancy weight. However, because women in resource poor settings often gain little
weight early in pregnancy, weight at booking can often be used as a proxy measure.70 The
Institute of Medicine recommends the following categories for use in categorizing women into
pre-pregnancy weight categories: BMI of <19.8 kg/m2 (underweight), 19.8-26.0 (normal
weight), 26.0-29.0 (overweight) and >29.0 (obese). A slightly lower cutpoint of BMI <18.5
kg/m2 has also been used in developing countries as suggestive of chronic energy
deficiency.70
Pregnancy weight gain: Women typically need to gain between 11-15 kg in weight to
meet the metabolic needs of pregnancy. This weight gain can be characterized into fetal
components including the conceptus (3.2-3.6 kg), the placenta and amniotic fluid (1.4-1.8 kg),
and the enlarged uterus (0.9-1.8 kg), as well as maternal components of tissue fluid (2.3-2.7
kg), plasma volume (1.4-1.8 kg) and body mass or fat stores (2.3-2.6 kg).64 Weight gain is
minimal early in gestation and mostly reflects uterine growth and blood volume expansion; in
the latter half of pregnancy the growing fetus and placenta make up most of the maternal
weight gain.64 In resource poor countries, average total gestational weight gains range from
4.8-9.0 kgs; much less than the 10.5-13.5 kgs reported from industrialized countries.70
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Among women living in resource poor settings, fetal weight makes up a larger proportion of
overall weight gain than in industrialized areas, indicating that the maternal components of
weight gain, including plasma volume expansion and fat store deposition, may be
compromised.
A strong body of evidence supports the finding of a positive association between total
pregnancy weight gain and LBW or SGA.15,73,75,89,93,94 A weekly weight gain of <0.24 kg or
0.24-0.57 kg (compared to 0.58-0.74 kg/week) was associated with a 3-fold and 2-fold
increased risk of SGA, respectively, in a study of rural indigent women in the southern United
States.81
Previous research suggests that pregnancy weight gain has varying affects on infant
outcome depending on the timing of weight gain. With the exception of a study by Brown et
al,95 first trimester weight gain has largely found to be unrelated to infant birth weight.96-98 In
contrast, gains in the second, or second and third, trimester have been associated with
newborn weight in a variety of settings. In Guatemala, Villar et al showed that late 2nd
trimester and early 3rd trimester weight gain was associated with higher mean birth weight.99
In another Guatemalan population, mid-pregnancy weight gain was shown to be more
important than late pregnancy gain in predicting birth weight.100 In Tanzania, Nyaruhucha
and colleagues showed that weight gain in the third trimester was significantly associated
with birth weight in multivariate analysis.101 Studies from industrialized countries have
demonstrated similar strong effects of second trimester or mid-pregnancy gains.93,96,98 These
trimester specific weight gain findings may suggest that maternal physiologic changes
occurring in the earlier half of pregnancy, including plasma volume expansion and fat
deposition, play a large part in maternal weight gain and an important role in fetal outcome.
Many studies of pregnancy weight gain have also demonstrated a variable effect based on
pre-pregnancy weight or BMI. In general, the importance of maternal weight gain appears to
diminish as pre-pregnancy weight increases. Among women with low weight gain, Strauss et
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al showed a decreasing trend in the risk of SGA with increasing baseline BMI.97 Niswander
demonstrated a similar trend using percent LBW as an outcome.76 Abrams and Laros saw a
statistically significant effect of maternal weight gain on birth weight in women who were
underweight, ideal weight and moderately overweight, but not among women in the obese
pre-pregnancy category.102 Similarly, Simpson noted an increase in mean birth weight with
increasing pregnancy weight gain in women with low and normal pre-pregnancy weight, but
not among women in the highest group (>160 pounds).90 Findings such as these lead to the
1990 Institute of Medicine recommendation that pregnancy weight gain norms be stratified
by maternal pre-pregnancy BMI status.103
Pregnancy weight gain can be assessed using measurements taken at least one month
apart and it is not absolutely necessary that an accurate estimate of gestational age be
known in order for the indicator to be useful. Cut offs for weight gain of <1.0 kg and <1.5 kg
per month throughout the second and third trimester have been suggested to identify women
with inadequate dietary intake and at risk of adverse pregnancy outcome.70 Lack of weight
gain or weight loss is indicative of a serious problem that requires immediate nutritional
intervention.
Mid-upper arm circumference (MUAC): Maternal body fat represent the largest
component of tissue gain during pregnancy.99 MUAC and skinfold thickness measures reflect
both fat and lean tissues stores. Early in pregnancy, maternal fat cells hypertrophy, fat
synthesis is increased, and lipolysis is inhibited to expand maternal deep and subcutaneous
fat stores and build an energy reserve.61,69,104 The deposition of fat in the early stages of
pregnancy indicate a positive energy balance.105 Later in pregnancy, there is a shift in
metabolism that favors lipolysis, and the fat mass diminishes in order to meet the increased
nutritional demands of the fetus.73,104 MAUC and skinfold thicknesses are highly correlated
with both maternal weight gain and BMI.70,104
Studies from resource poor populations have had conflicting results concerning this
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indicator. For example, in Guatemalan women, Li and colleagues100 showed no association
between MUAC change while Lechtig found that MUAC was as good as third trimester
weight gain for predicting birth weight.106 In Zimbabwe, Friis et al demonstrated a nearly 2-
fold increase in the risk of LBW among women with low arm fat area.79
Previous studies of MUAC and skinfold thickness in industrialized and resource poor
settings have identified certain trimester patterns of fat accrual associated with LBW and
SGA. For example, studies concentrating on first trimester have shown no relationship
between fat mass and poor birth outcome.94,107 However, failure to accrue fat during the
second trimester of pregnancy has been associated with lower birth weight.73,99,105 In
contrast, MAUC that continues to increase into the third trimester are associated with lower
attained birth weight73,85,82 which may indicate that the fetus was not able adequately mobilize
maternal fat stores late in pregnancy.103
For one time screening, MUAC cutoffs between <20.8 cm and < 23.5 cm have been
suggested to identify women with inadequate nutritional status.70 MUAC in this range have
been associated with predicting LBW, fetal, and infant deaths with an adequate level of
sensitivity and specificity. Change in monthly or trimester specific MUAC or arm fat area
measurements have also been used to describe fat accretion in several studies. However, in
resource poor settings, where women may gain very little, or even lose MUAC, the
usefulness of change in MUAC as a monitoring tool may be limited.70
Specific Aim 2: Utilize prospectively collected ultrasound data to develop a fetal size for
gestational age nomogram for a resource poor population with high malaria prevalence
Rationale: IUGR is often defined as an estimated fetal weight of less than the 10th
percentile of a standardized fetal weight-for-gestational age nomogram.16 The choice of
standardized nomogram can influence the predictive properties of this definition. In fact,
depending on the standard population, cut-offs to define IUGR can vary by up to 500
grams.108 Most fetal weight nomograms were derived from European or American Caucasian
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populations and represent a narrow range of genetic diversity or environmental conditions.109
Environmental factors that are prevalent in resource poor populations, such as maternal
infections and chronic under-nutrition and micronutrient deficiency, can significantly affect
fetal growth. 2,15 Therefore, It is likely that fetal weight nomograms created from industrialized
countries are not appropriate standards for diagnosing IUGR in resource poor populations.
Previous ultrasound studies of African populations have largely found lower mean values
for fetal biometry and estimated fetal weight for gestational age compared to industrialized
standards. Okonofau and colleagues conducted two ultrasound studies among Nigerian
women during the late 1980s. They found that the BPD110 and AC111 of Nigerian fetuses
were consistently lower at all gestational ages between 20 to 40 weeks when compared to a
European standard. They also calculated the BPD to AC ratio as a possible means to
assess symmetrical vs. asymmetrical IUGR patterns.111 A study conducted in Zimbabwe
showed nearly identical smoothed centile results for the modeled BPD measurements as
demonstrated by Okonofau and colleagues.112 Another study from Nigeria, however, found
no significant differences between the BPD of Nigerian fetuses and European fetuses until
late in pregnancy when the Nigerian fetuses had slightly smaller measurements.113
Research conducted in other resource poor populations display a similar trend as the
African data. In Bangladesh, Spencer and colleagues found that the AC and EFW of
Bangladeshi fetuses were smaller than fetuses of white women at 28, 32 and 36 weeks
gestation.114 With advancing gestational age, the 50th percentile HC, AC and FL for Peruvian
fetuses fell progressively below the 50th percentile of reference populations from the United
States and Britian.115 Two studies of Indian women found lower mean fetal AC 116,117 and
BPD117 after 24 weeks, compared to whites.
In sum, these studies provide a body of evidence that fetal size nomograms developed for
industrialized populations are likely to overestimate fetal weight centiles for resource poor
populations, thus leading to diagnosis of an inappropriately high proportion of fetus as IUGR.
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Statistical development of fetal size nomograms: There are three main uses of fetal
nomograms in obstetric practice: 1) to assess the size of a fetus of known gestational age
against a reference standard at a certain point in time (size nomogram), 2) to assess the
growth rate of a fetus between two time points against reference data (growth nomogram),
and 3) to estimate the gestational age of a fetus from its fetal size.118 The second and third
uses are beyond the scope of this dissertation; however, it is important to make a distinction
between fetal size nomograms and fetal growth nomograms. Fetal size nomograms are
often erroneously referred to in the literature as “growth nomograms” or “growth curves” but
they should not be used to make assumptions about, or to monitor, fetal growth progress
over time.
Because growth nomograms inherently describe how a fetus is growing conditional upon
its size a few weeks or months prior, it is essential that they be derived from longitudinal (or
serial) measurements from each fetus. Many past researchers have also attempted to
develop fetal size nomograms from longitudinal ultrasound data, but they utilized
inappropriate statistical techniques for this application. For example, many investigators
treated the longitudinal data as if it were cross-sectional data (i.e., each women scanned
only once).119,120,121 By assuming statistical independence, this approach ignores the high
correlation amongst biometric parameters over time (gestational age) and presumes that the
fetal growth velocity, and the estimated model residual errors, are constant over time. These
assumptions are not appropriate for fetal growth data, which generally demonstrates a
pattern of increased variability in EFW with increasing gestational age. Several authors
attempted to improve the statistical methods used to analyze longitudinal data for creating a
fetal size nomogram by fitting a separate regression curve to each fetus and using the
average variation (i.e., average of the individual regression coefficients) among these curves
to derive the size centiles.122,123 This method, however, is also flawed and leads to outer
centiles that are too narrow because it only accounts for between-fetus variation.124 In a
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series of papers published in the mid-1990’s, Altman and Chitty pointed out the errors in
these techniques and recommended that fetal size nomograms only be derived from cross-
sectional data.118,124 Further, they proposed a set of techniques to appropriately analyze
cross-sectional data which modeled the mean and standard deviation (SD) of the data
separately and then produced the centiles from the relationship mean ± z(SD) where z is the
standard normal deviate.
The introduction of mixed effects modeling (also known as hierarchical or multilevel
modeling), provided a new statistical technique that addresses some of the limitations
discussed above by considering both the between- and within-fetus variation in the
calculation of fetal size nomogram reference centiles from longitudinal data. For this specific
aim, we utilized a mixed effect modeling approach suggested by Royston,125 to develop a
fetal size nomogram for this Congolese population.
CHAPTER 2:
RESEACH DESIGN AND METHODS
The specific aims of this dissertation are explored with data collected from a longitudinal
cohort study of 182 pregnant women identified during routine antenatal care at Binza
Maternity in Kinshasa, Democratic Republic of Congo between May 2005 and May 2006.
Information regarding study design and data collection methodology that is relevant to both
specific aims is provided first. Specific details about the study population (inclusion and
exclusion criteria), variable definitions, and statistical methods for each specific aim analysis
are provided separately in subsequent sections.
Study design and data collection
Setting: Binza maternity is Kinshasa’s second busiest maternity with approximately 7,000
deliveries per year. The maternity has been operating in urban Kinshasa for over 30 years.
Italian nuns are responsible for the overall functioning/administration of the maternity;
Congolese nationals conduct all medical and nursing aspects. The maternity includes simple
but effective facilities for caring for premature infants, and an outpatient unit for seeing
infants in post-partum follow-up. Women with significant blood loss during delivery or who
require surgical intervention are transferred to a nearby obstetrical referral hospital. The
mean age of women delivering at Binza Maternity is 27 years and the mean gestational age
at first antenatal presentation is 26 weeks. Nearly one-third of women are parasitemic at first
antenatal presentation. Over 80% of the women who receive antenatal care at Binza return
to the maternity to deliver.
Recruitment: Pregnant women were recruited from the population of new antenatal care
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attendees at Binza maternity. Eligibility screening occurred in a two phased process. During
routine antenatal registration and clinical evaluation at the maternity, an initial screening was
employed that utilized patient reported last menstrual period (LMP) and maternity recorded
fundal height information. For the first round of recruitment (May-July, 2005), women
determined to be less than 23 weeks gestation via either of these methods were asked to
provide written consent to have an ultrasound examination performed to confirm gestational
age. During the second round of recruitment (October-November, 2005), a more stringent
set of criteria was utilized to minimize costs and time spent screening and consenting women
who would likely not be eligible for enrollment in the study. These criteria emphasized LMP
dates as we found LMP to be a more reliable indicator of gestational age than the fundal
height measurement. For the new criteria, if LMP was known, women determined to be less
than 23 weeks gestation were invited for an ultrasound examination. If LMP was not known,
then the fundal height cutoff was considered for determination of women to approach for
ultrasound screening. Women who met the initial screening criteria were approached by a
study coordinator and invited to consent to return to the maternity 3-5 days later for an
ultrasound examination to confirm gestational age.
During the second phase of recruitment, women had a baseline ultrasound examination,
which assessed fetal biometric measures including BPD, HC, AC, and FL. These
measurements were used to estimate gestational age126 and fetal weight27 using the Hadlock
algorithms. For fetuses in the first trimester, the crown-rump length was used to estimate
gestational age. All women who were potentially eligible for enrollment also had amniotic
fluid volume (four quadrant method) and placental location recorded. To be eligible for the
study, women had to have a singleton pregnancy with an ultrasound derived gestational age
of 22 weeks, 0 days or less, be 18 years of age or older and agree to be tested for HIV.
Women with high blood pressure at baseline (systolic blood pressure > 140 mmHg and/or
diastolic > 90 mmHg), multiple gestations or a detectable fetal abnormality were excluded
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from the study. Women with evidence of placenta previa, fetal abnormalities or multiple
gestations during ultrasound were referred to the Department of Obstetrics and Gynecology
at the Clinque Universitarie in Kinshasa for high risk pregnancy follow-up care. All
ultrasounds were conducted by a trained Congolese obstetrician-gynecologist.
Figure 2.1 summarizes the results of recruitment. Of 1,111 new antenatal care attendees,
33% (n=370) met all initial screening criteria and were scanned to determine gestational age.
Of those, 182 were eligible and consented to the longitudinal study. Reason for ineligibility
included absent for ultrasound (n=24), twin pregnancy (n=6), no viable fetus present (n=4) or
gestational age greater than 22 weeks, 0 days (n=154).
Figure 2.1. Recruitment results for longitudinal study, Kinshasa, Democratic Republic
of Congo, 2005-2006
Baseline visit: After the ultrasound examination, all eligible women met with a study
recruiter who explained the goals and procedures of the study and administered written
informed consent to be enrolled in the longitudinal study. After obtaining informed consent,
women were interviewed about sociodemographic characteristics, alcohol, tobacco and drug
1,111 new antenatal
care attendees
378 identified as potentially
meeting initial screening criteria
370 met all three initial screening criteria
and consented for ultrasound to
determine gestational age
8 did not meet all
three initial
screening criteria:
2: maternal age
6: gestational age
346 present for
ultrasound and scanned
24 absent for
ultrasound
164 not eligible
6: twin pregnancy
4: no viable fetus
154: > 22 weeks, 0 days
182
eligible & enrolled
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use, and medical and obstetric history. Current malaria symptoms, recent use of anti-malarial
drugs, and use of insecticide treated bed nets were also assessed.
A medical examination was conducted to collect maternal anthropometric measurements,
blood pressure, pulse, temperature and physical signs of anemia (Table 2.1). A urine test for
albumin and a hematocrit test were conducted in our on-site laboratory. Malaria thick and
thin smears and filter paper samples were colleted from fingerprick blood samples. Malaria
slides were initially read on site for a gross determination of parasitemia; quality control,
assessment of parasite density and identification of parasite sub-type was conducted the
following day at the Ecole Sante Publique de Kinshasa.
All women enrolled in the study participated in HIV voluntary counseling and testing
services as part of a Glaser Foundation-supported Preventing Mother to Child Transmission
of HIV program at Binza maternity. Women identified as HIV positive, and their infants,
received Nevirapine treatment per that program’s protocol.
In accordance with Congolese National Policy, all enrolled women received two doses of
presumptive therapy with sulfadoxine-pyrimethamine (SP: 1500 mg sulfadoxine + 75 mg
pyrimethamine) between 16 and 27 weeks, and again between 28-32 weeks, regardless of
malaria status. The first dose coincided with the baseline visit for most of the women enrolled
in the study (women less than 16 weeks at enrollment received their first dose of SP at the
first follow-up visit). All women also received iron supplementation as part of routine
antenatal care at Binza maternity.
At the conclusion of the baseline visit, women were provided with a study appointment
card, an insecticide treated bed net, and reimbursement for round trip taxi fare. Women were
instructed not to take any anti-malarial medication that was not provided through the study
and to return to the clinic any time they felt ill or had any symptoms of malaria illness.
Women were also interviewed to complete a Participant Locator Form which contained
detailed information about her address (street, house number, quartier, and commune), a
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reference location near her address (i.e., a popular bar or market), a phone number (if
available), as well as similar information for a reference person (i.e., a mother or sister). This
form was used to locate participants who missed one of their scheduled appointments.
Table 2.1. Summary of ultrasound, clinical and laboratory measurements, Kinshasa,
Democratic Republic of Congo, 2005-2006
Visit Clinical Measurements
Baseline  Clinical history
 Sociodemographics
 Last menstrual period
 HIV test and counseling
 Ultrasound examination
 Fundal height
 Peripheral parasitemia and
assessment for fever
 Filter paper sample
 1st SP dose1
 Height, weight, mid-upper arm
circumference
 BP, pulse
 Hematocrit
 Urine test
 Assess for edema
Follow-up
(each
month)
 Ultrasound examination
 Fundal height
 Peripheral parasitemia and
assessment for fever
 Filter paper sample
 2nd SP dose1
 Weight, mid-upper arm
circumference
 BP, pulse
 Hematocrit2
 Urine test
 Assess for edema
Delivery Women
 Peripheral parasitemia
 Filter paper sample
 Placental biopsy
 Hematocrit
 Maternal mortality
Infant
 Birth weight
 Length (crown-heel, crown-rump)
 Head circumference
 Abdominal circumference
 Gestational age
 Infant mortality
1 SP was given to all women between 16 and 27 weeks, and between 28-32 weeks gestation,
regardless of malaria status.
2 Hematocrit tests performed at every other follow-up visit.
Follow-up: Participants returned to the maternity for follow-up every month until delivery.
This resulted in approximately four to five follow-up visits over the course of the study. At
each follow-up visit, an ultrasound examination of fetal biometry was conducted to estimate
fetal weight (Table 2.1). Amniotic fluid volume (four quadrant method) and placental location
were also recorded. Additionally, Doppler assessment of uterine and umbilical artery flow
was performed. A medical examination was conducted to collect maternal anthropometric
measurements, blood pressure, pulse, temperature, urine test and physical signs of anemia.
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Malaria thick and thin smears and filter paper samples were colleted from fingerprick
samples. Hematocrit tests were conducted at every other visit.
At all visits, any woman found to have a positive malaria slide was provided with treatment
by the study. Treatment determination for malaria positive women was done in collaboration
with the attending physician at Binza maternity. Typically, any woman found to have
parasitemia was first treated with SP. If a woman had a subsequent positive parasitemia
within a month of treatment with SP, another drug was selected. Most often, quinine (along
with sulbutamol to control uterine contractions) was prescribed. Depending on a woman’s
gestational age and her willingness to take quinine, Manalaria (a locally produced herbal
drug), Artesunate or Camoquine were also sometimes prescribed. All treatments were
provided to patients free of charge. The second presumptive dose of SP was given to
women at the visit that coincided with approximately 28-32 gestational weeks. At the
conclusion of each follow-up visit, women were given reimbursement for round trip taxi fare.
If a study participant failed to present to the maternity for her regularly scheduled follow-up
visit, an active surveillance mechanism utilizing the Participant Locator Form was activated.
As a first step, we attempted to contact her, or her reference contact, via phone. If no
response was obtained after two phone calls, a study nurse traveled to the participant’s
home to locate the patient and offer her a ride to the maternity or reschedule her
appointment for later that week.
Interim study visits: Women were instructed to return to the maternity if they ever felt ill,
had fever or other symptoms of malaria. All interactions with the patient that occurred
outside of a regularly scheduled study visit were recorded on an Interim Visit Study Form.
At these visits, medical care was provided by the maternity and a member of our study
staff assessed the patient for clinical symptoms of malaria and prepared a thick smear
and filter paper sample. All medical procedures performed and medications prescribed
by the maternity were recorded. The study paid for any medication and laboratory tests
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the women required. There was a total of 172 interim study visits during follow-up.
Delivery: All women were encouraged to deliver their infants at Binza maternity and
were reimbursed for one-third of the delivery-related fees. Before delivery a hematocrit,
thick and thin smear, and filter paper sample were collected (Table 2.1). If these samples
were missed before a woman went into labor, we attempted to collect them within 24
hours after delivery. After delivery, a placental thick blood smear and a placental biopsy
were taken for assessment of placental malaria. The infant was weighed and infant
anthropometrics (crown-heel, crown-rump, head and abdominal circumference) recorded
within 24 hours of delivery. Information about the labor and delivery, including
complications, maternal and fetal death, were recorded.
For women who were unable or unwilling to delivery at Binza maternity, or who initiated
labor at Binza maternity but were later transferred due to complications, our staff would
travel to the hospital or clinic where the women delivered as soon after delivery as
possible to collect the necessary samples and infant information.
Figure 2.2 summarizes the results of follow-up and delivery. Enrolled women participated
in a total of 1,151 study visits (979 regular appointments that included an ultrasound scan
and 172 interim visits which did not include a scan). There were a total of 11 regular
appointments in the 1st trimester, 423 in the 2nd trimester, and 545 in the 3rd trimester. On
average, women participated in five follow-up visits (SD=1 visit) and were enrolled for 18
weeks (SD=3 weeks). Delivery information was collected for 180 women (missing
information included one maternal death and one woman with unknown delivery location).
There were 167 term deliveries, eight preterm deliveries, three stillbirth/pre-term deliveries,
and one preterm/early neonatal death.
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Figure 2.2. Follow up and delivery results for longitudinal study, Kinshasa, Democratic
Republic of Congo, 2005-2006
Delivery information collected for
180 of 182 women
• 1 maternal death
• 1 women unknown delivery
location
Birth outcomes
• 167 term deliveries
• 8 preterm deliveries
• 3 stillbirth/pre-term deliveries
• 1 preterm/early neonatal death
Baseline visit
N=182
Follow-up visit #1
N=182
Follow-up visit #2
N=180
1 maternal death
1 moved out of Kinshasa
Follow-up visit #3
N=180
Follow-up visit #4
N=161
Follow-up visit #5
N=74
Follow-up visit #6
N=19
Follow-up visit #7
N=1
4 preterm deliveries & 3 stillbirth/preterm
1 early neonatal death,
1 decided to stop follow-up
10 term births
2 preterm deliveries
85 term births
1 preterm delivery
54 term births
1 preterm delivery
17 term births
1 term birth
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Ultrasound measurements
All ultrasounds were performed using a GE Logicbook Ultrasound System. All ultrasound
images were stored on CD-ROM for blinded reassessment at the University of North
Carolina, Chapel Hill. Victor Lokomba, an obstetrician-gynecologist from Clinque
Universitarie in Kinshasa received intensive training in ultrasound technique and performed
all ultrasounds.
Fetal biometry: Using standard techniques, HC and BPD were measured from an image
that displayed the fetal head in an axial plane that included the thalamus and cavum septum
pellucidum. The BPD was measured by placing the calipers from leading edge to leading
edge (outer to inner skull table) and the HC was measured using an ellipse trace of the
outline of the fetal head. AC was measured from an image in which the junction of the
umbilical vein and portal sinus were visible. The ellipse function was used to trace the
extreme perimeter of the fetal abdomen. FL of the femoral diaphysis was also measured.
These measurements were used to estimate gestational age126 and estimated fetal weight27
using the formulas of Hadlock.
Measurement of intrauterine environment (fundal height and amniotic fluid volume):
Oligohydramnios is a common finding in pregnancies affected by IUGR. The intrauterine
environment was assessed clinically by measurements of fundal height and amniotic fluid
volume. Amniotic fluid volume was assessed using the four-quadrant technique and the
normal values reported by Moore and Cayle.127
Assessment of placental location: Placental position was characterized as anterior,
posterior, left or right lateral, previa/low lying, or fundal. Lateralization was determined by the
side on which the majority of the placenta was located. Low lying/previa was further
characterized as Type 1-Type 4 as follows:
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Type 1: The placenta is mainly in the upper segment of the uterus but encroaches on
the lower segment
Type 2: The placenta extends to, but does not cover, the internal opening into the
cervical canal
Type 3: The placenta covers the internal os of the cervical canal during the later
stages of pregnancy but does not cover it completely as the cervix dilates during labor
Type 4: The placenta completely covers the internal os of the cervical canal, even
when dilated
Laboratory and clinical measurements
Peripheral malaria parasitemia: At baseline, all follow-up visits and delivery, peripheral
parasitemia was assessed by thick and thin smears. Giemsa-stained smears were assessed
for parasitemia by a laboratory technologist trained at the Institut Superieur de Technologie
Medicale in Kinshasa. Parasite sub-type was determined and parasite density was quantified
by counting the number of parasites against 200 white blood cells and converted to numbers
of parasites per µl under the assumption that there was 6000 WBC per µl.
Filter paper samples: At baseline, all follow-up visits and delivery, a filter paper sample of
maternal peripheral blood was taken and stored for future laboratory analysis. From the
finger prick puncture, 2-3 large drops of blood were formed and lightly touched onto the filter
paper. Five circular blood spot were collected from each woman. The blood spots were dried
thoroughly for at least four hours before being stored individually in a sealed plastic storage
bag with a desiccant pack. All samples were stored at 4ºC until sent to the University of
North Carolina, Chapel Hill for processing.
Placenta malaria parasitemia and histology: Placentas were collected after delivery and
stored at 4°C for processing within 24 hours of delivery. An incision was made at a healthy
pericentric area of the placenta for collection of placental blood smears and biopsy samples.
Several drops of pooled blood were transferred to a glass slide and prepared according to
the peripheral malaria blood smear procedures listed above. Following the procedures of
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Rogerson,12 two placental biopsy samples (approximately 1 cm3) were collected and placed
into 10% neutral buffered formalin. Samples were stored at 4°C until sent to the University of
Kinshasa Service d’anatomie Pathologique for processing. Samples were embedded in
paraffin wax using standard techniques and paraffin sections of approximately 5 µm thick
were stained with Gurr’s modified Giemsa and/or hematoxylin and eosin (H&E) and
examined under light microscopy and polarized light (to assess the deposition of malaria
pigment). Intervillous cells were examined under oil immersion for presence of parasites and
fibrin. The following classification was used to assess the severity of parasites in the
erythrocytes, and hemozoin pigment in fibrin and in monocytes: 1) Absent, 2) Scant, 3) Mild,
4) Abundant.
Hematocrit/anemia: At baseline, alternating follow-up visits and delivery, fingerprick blood
was collected into a heparin coated capillary tube and spun for 10 minutes in a hemotocrit
centrifuge (Clay Adams, Readacrit). The percent hematocrit was recorded.
Preeclampsia (proteinuria/blood pressure): At each study visit, a urine specimen was
tested for the presence of protein and a blood pressure measurement taken as clinical
indicators of preeclampsia (sometimes called toxemia or pregnancy-induced hypertension),
a disorder often characterized by high blood pressure and large amounts of protein in the
urine.
Maternal anthropometric indicators: Using standard techniques,128 maternal weight was
measured on a UNICEF digital scale (SECA Model 890) to the nearest 0.1 kilogram and
height (without foot-wear or head cover) was measured to the nearest 0.1 cm. MUAC was
measured with cloth tapes on the right arm at the midpoint between the acromial and
olecranon processes of the scapula and ulna, respectively. The measurement was made to
the nearest 0.1 cm while the arm was hanging freely, with the cloth tape snug to the skin, but
not compressing the underlying tissue.
Infant anthropometrics: Using standard techniques,128 birth crown-heel and crown-rump
32
length were measured using a pediatric length board within 24 hours of birth. Head and
abdominal circumference were measured to the nearest 0.1 cm using a measuring tape.
Birth weight was recorded within 24 hours of birth to the nearest gram (LARIO Scale, Soc.
Curion & Company, Como, Italy).
Quality control
Malaria parasitemia: For quality assurance, a 10% sample of all malaria thick smears was
assessed independently by an experienced laboratory technician at the University of
Kinshasa. Of 140 slides examined, there was one discordant positive and one discordant
negative between the two technicians for a sensitivity of 92% and a specificity of 99%.
Ultrasound images: All ultrasound images were stored on a CD-ROM and a 10% sample
of biometry and Doppler images was assessed for quality by a Maternal-Fetal Medicine
physician at the University of North Carolina, Chapel Hill. 92% of the reviewed images were
deemed of adequate quality for clinical assessment; 7% of questionable quality and 1% poor
quality (i.e., not all biometry landmarks clearly visible, shadowing in the image or poor tracing
of the length of circumference).
We conducted a small study comprised of 10 women to assess the intra-operator
variability in measuring fetal biometry. The correlation between two independent
measurements on the same fetus was r=0.99 for each of biparietal diameter, head
circumference, and femur length, and r=0.98 for abdominal circumference.
Data entry and data management
Data entry: All data was entered locally using an EpiInfo database designed specifically for
the study. Quality control elements of the data collection process included: (i) routine
checking for completion of all data items at the maternity before women are checked out at
the end of their appointment; (ii) EpiInfo pre-programmed ranges of plausible values for all
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continuous numeric data fields (i.e., temperature, height, weight); (iii) EpiInfo pre-
programmed ranges of allowable values for all categorical responses; (iv) EpiInfo pre-
programmed skip patterns to ensure that no data is entered for questions that should be
skipped; (v) required data entry fields (such as ID numbers and dates) that must be entered
by the data entry clerk in order to continue with entry; and vi) re-entry of a 10% sample of
forms by an independent data entry clerk for comparison to the larger database using the
EpiInfo Data Compare functionality.
Data cleaning: The EpiInfo data base was transferred into SAS and SPSS datasets for
data cleaning. Data cleaning steps included: (i) identifying data that is missing from required
fields and attempting to locate that data if possible; (ii) checking to ensure that skip patterns
were properly followed; (iii) descriptive statistics of all continuous variables to identify outlier
values; (iv) ensuring that dates match up on all forms for a given visit; (v) translating dates
into American format (DD/MM/YYYY); and (vi) adding descriptive labels and user defined
formats to each variable.
Assessment of missing data, drop-outs: Overall, missing data and attrition for this study
was extremely low. We minimized “intermittent” missing data (in which a woman misses a
follow-up appointment but then returns to complete the study) by our active surveillance of
“no-shows.” Women were characterized as “lost to follow-up or drop-out” if they left the study
before completing all follow-up visits or they did not deliver at Binza maternity and were not
able to be located at their delivery location. Follow-up data are missing for one maternal
death and one woman who moved out of the study area (both occurred after visit #1). No
delivery data was available for the maternal death and for one woman who completed all
study visits but could not be located for delivery. Only partial delivery data (date of birth, birth
weight and maternal and neonatal vital status only) was available for 10 women who
delivered at another maternity and were released before our staff could examine the infant to
collect anthropometrics.
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This very low rate of missing data is not likely to bias the results significantly. Further, the
longitudinal data analysis techniques used in this dissertation will include all available
antenatal data for a woman, regardless of the number of follow-up visits that she contributes.
Analyses for Specific Aim 1: Describe the association between maternal malaria infection
and intrauterine growth restriction and determine if maternal nutritional status modifies this
relationship
Study population: In the full study cohort, 182 women were eligible and consented to the
longitudinal study. For this analysis, we excluded five HIV-positive women (3%) to yield a
final sample size of 177 women. HIV positive women were similar to HIV negative women
with respect to their socio-demographic and obstetrical characteristics as well as the
gestational age at enrollment. The frequencies of malaria and IUGR were also similar with
those of non-HIV infected women. The 177 included women completed a total of 1,120 study
visits. On average, women received five ultrasound scans (range two to eight).
Determination of gestational age: For this analysis, gestational age was defined in
rounded weeks according to the ultrasound derived menstrual age algorithm of Hadlock
[MA=10.85 + 0.060*HC*FL + 0.6700*BPD + 0.1680*AC].126 Because an accurate estimate of
gestational age is an important factor in the assessment of IUGR, we also considered
restricting this analysis to only women who had a “certain” gestational age (defined as an
LMP date within ±14 days of the ultrasound derived date). All of the following analytic steps
were also run on this sub-population (n=145 women, 608 study visits and 51 episodes of
IUGR). Overall, the results were not appreciably different from those obtained using the “full”
data set which included all women and utilized the ultrasound derived menstrual age as the
anchor for gestational age determination at each follow-up visits. Further, several of the
models run on the restricted data set had problems converging due to small sample size
when attempting stratified analyses. Thus, we ultimately decided to present findings for the
full study population.
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Outcome definition: Estimated fetal weight was calculated at each ultrasound using the
formula by Hadlock [log(EFW)=1.3596 - 0.00386*AC*FL + 0.0064*HC + 0.00061*BPD*AC +
0.0424*AC + 0.174*FL].27 For this analysis, IUGR was defined at each ultrasound as a binary
outcome of <10th percentile of fetal weight for attained gestational age using the Hadlock
fetal standard curve.129
Exposure and covariate definitions: The following definitions were used to define the main
study exposures:
Malaria infection: Among the 177 women included in this analysis, there were a total of
171 positive malaria smears. Before defining the malaria variables for this analysis, we
attempted to identify probable recrudescent episodes. To do this, we examined each
episode of malaria and determined the number of days between that episode and the most
recent prior episode. Any episodes that occurred within 14 days of a previous positive were
considered to be probable recrudescent cases, and not representative of a “new” incident
infection. In total, 14 probable recrudescent episodes were identified and excluded from
analysis.
Using the remaining 157 episodes, we created two malaria variables. The first was a time-
dependent measure of incident infection (called malaria parasitemia at visit) which
represents the effect of an incident infection that initiated during the interval between a
woman’s previous visit and the study visit in which the IUGR measurement was taken. The
second is a time dependent measure of the cumulative number of positive antenatal
parasitemia episodes (called cumulative positive parasitemia) which represents the total
number of times that a woman had a positive smear up to and including the study visit in
which the IUGR measurement was taken.
Maternal height: Short maternal stature was defined as height <150 cm.
Maternal pre-pregnancy weight or BMI: As pre-pregnancy weight was not available, we
utilized maternal weight at enrollment to calculate baseline body-mass index (BMI), with low
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baseline BMI defined as <19.8 kg/m2. Although this proxy of pre-pregnancy weight may
have over-estimated true pre-pregnancy weight, any error was likely minimal as women in
resource poor countries gain little weight early in pregnancy and these participants were
enrolled in the first or early second trimester.70 Further, the 10th percentile baseline BMI value
for this population was nearly identical to the cut point of the standard weight-for-height chart
used to define the underweight category in this analysis (19.8 kg/m2 for the standard vs.
19.7 kg/m2 for the Kinshasa population), suggesting that our proxy was a fair estimate of
pre-pregnancy BMI.
Pregnancy weight gain: Change in maternal weight was calculated between each
monthly visit, and was categorized as low monthly weight gain (<1.5 kg gain per month) or
adequate monthly weight gain (1.5 kg gain per month). After completion of the study, it was
discovered that the digital scale malfunctioned half way through the study period
(systematically added an unknown weight to all measurements taken after this time). This
error largely involved weight measurements taken during the last follow-up visit for women
enrolled early in the study and the first or second follow-up visit for the women recruited later
in time. To account for this in data analysis, we removed the suspect data points before
calculation of the change in weight variable. Next, to ensure the validity of measurements
taken after the malfunction, we ensured that the average weight change between visits
before and after the scale malfunction were similar. Due to these statistical adjustments,
complete data on weight change is available for 588 observations.
MUAC: Change in MUAC during pregnancy was dichotomized as loss (<0 cm change)
or gain (0 cm change), over three distinct time periods: (i) monthly change between
study visits, (ii) change over the entire second trimester, and (iii) change over the entire
third trimester. These time periods were selected so that we could explore whether there
were any differential effects of maternal fat accretion during various trimesters as
suggested by previous work.73,105
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Socioeconomic status (SES): SES was defined using a composite variable, with those
who were currently employed (women or her partner) and living in a home with toilet facilities,
a nearby water source and electricity characterized into the high SES strata.
Anemia: Anemia was defined as a time dependent hematocrit of less than 30%.
Maternal age: Maternal age was defined as a categorical variable (18-24 years, 25-29
years and 30 years and older).
Gravidity: Gravidity was defined as a binary variable (gravida 1-2 and 3).
Statistical analysis: A series of descriptive analyses and crude and multivariate modeling
analyses were performed on the data.
Descriptive analyses: Frequencies of demographic, socioeconomic, treatment and
pregnancy characteristics were calculated for all participants and by IUGR status using
routine categorical data analysis techniques.
Basic survival analysis: In this study, the prevalence of malaria was highest during
the baseline visit and declined over gestation due in part to provision of presumptive
treatment and active case management of all positive malaria smears. The IUGR
outcome was, conversely, less prevalent early in pregnancy and increased until near
term. Before making assumptions about the overall risk of IUGR associated with malaria
over the whole pregnancy, we felt it was important to ensure that the relationship
between these two variables did not change appreciable over time. To investigate this,
we ran a simple survival analysis using proportional hazards modeling. Details about this
analysis can be found in Appendix A. Overall, we found that the relationship between
malaria and IUGR did not change over time (the hazards were proportional over
gestation) so we felt comfortable moving forward with the longitudinal analyses
discussed below.
Log-binomial models for the binary IUGR outcome: The full data set had 1,120
visits in which an ultrasound measurement was conducted. However, because there is
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little variation in fetal weight through the first trimester, IUGR is not typically seen until the
second trimester. Thus, for these models, we left-truncated all person-time data at 22
weeks gestation, resulting in a total of 758 visits with an IUGR measurement available for
analysis. To account for the missing data that resulted from correction of the maternal
weight gain variable, a second set of models were fitted for the 588 visits for which
complete data were available for all exposures and potential confounders. Maternal
characteristics, under-nutrition and malaria status, and gestational age distribution of
IUGR for the 170 visits excluded in the complete data analysis were similar to those of
the entire study population.
Unadjusted and adjusted risk ratios (RR) and 95% confidence intervals (CI) were
derived from log-binomial regression models for the binary IUGR outcome. Generalized
estimating equations methods based on the exchangeable “working” correlation structure
were used to account for the correlated nature of repeatedly measuring the outcome on
fetuses over the course of pregnancy.130
As an initial step, crude models were fitted separately for each exposure (incident and
cumulative malaria infection, baseline BMI, maternal height, maternal weight gain and
MUAC). As there is evidence to suggest that maternal weight gain and MUAC may have
differential fetal growth effects depending on pre-pregnancy nutritional status, models for
these two exposures were stratified for baseline BMI status.73,102 As well, models for
these two exposures stratified by trimester of pregnancy were also fitted.73,105 96,97 The
trimester specific models are not adjusted for any confounding factors as the log-
binomial models for the weight gain exposure variable would not converge with an
exchangeable working correlation matrix due to small sample size.
To investigate if poor maternal nutritional status was an effect measure modifier of the
relationship between maternal malaria infection and IUGR, a second set of log-binomial
models were fitted that contained the malaria variable, the nutrition variable and an
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interaction term between the two variables. Risk ratios for the effect of malaria, at both levels
of the various nutritional status variables were derived from this model. A P-value of <0.15
for the interaction term was considered significant.131
For all exposures, multivariate models were also constructed using a set of candidate
confounders identified from a conceptual model and relevant literature. For each covariate,
initial categorical analyses were performed to determine which variables met the statistical
definition of confounding, that is, were associated with both the IUGR outcome and the
malaria (or nutrition) exposure variables. Next, a backwards elimination procedure was used
to determine the set of covariates to include in each multivariate model. From a full model
that included all potential confounding variables, the variable with the highest Wald Chi-
square P-value was dropped from the model. The dropped variable was retained in the
model if the RR for the main exposure changed by greater than 10%; otherwise it was
removed and the model was refit dropping the variable with the next highest Wald Chi-
square. This process was repeated with all candidate confounders until a final model was
chosen. Variables may have also been retained in the model if their inclusion significantly
improved the precision of the confidence interval for the main exposure RR.
The following variables were assessed as potential confounders of the malaria exposures:
maternal age, gravidity, SES, height, baseline BMI, weight gain, and MUAC change. The
following variables were assessed as potential confounders of the under-nutrition exposures:
maternal age, gravidity, and SES.
Mixed effect models for the continuous estimated fetal weight variable: We
undertook a secondary analysis to assess the effects of malaria and maternal under-nutrition
on mean fetal weight. Linear mixed effect models were fitted to data for the 758 follow-up
visits that occurred after 22 weeks (see Appendix B for a detailed overview of the mixed
effect model). Gestational age was modeled as rounded weeks based on the ultrasound
derived date. In the mixed effect models, malaria, treatment, anemia, weight gain and MUAC
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changes were analyzed as a time dependent variables and maternal sociodemographic
factors, height and baseline BMI were modeled as time independent covariates. Models
were built utilizing the following steps.
First, various techniques were used to identify a suitable transformation of time to
adequately capture the nonlinear relationship between fetal weight and gestational age.
The addition of a linear, quadratic and cubic term for gestational age was found to
provide similar fit than models utilizing splines or fractional polynomials, so we decided to
utilize the standard polynomial for simplicity.
The first model investigated contained only a random intercept that allowed the fetal
weight at the baseline gestational age to vary between women. A -2 log likelihood ratio test
was used to compare the random intercept model to a model with only fixed effects. This test
showed that the addition of the random intercept was highly significant in the model so a
random intercept was considered.
In the next step, we tested the need for adding a random slope component to the model
(for the time variable) which would allow the slope or growth trajectory of each fetus to differ.
These models had problems converging, even after relaxing the convergence criteria. From
the few models that would converge, the addition of a random slope did not explain an
appreciable amount of the overall model variation and we therefore decided not to include it
in the final models. Models for both malaria exposures and the under-nutrition indicators
were fitted. Potential effect measure modification of the IUGR-malaria relationship by
maternal under-nutrition was also assessed.
The results of these mixed effect model analyses can be found in Appendix C. A negative
value for the beta coefficient indicates a lower fetal weight in the malaria group, whereas a
positive value for the beta coefficient indicates higher fetal weight in the malaria infected
group.
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Power calculations: Power calculations appropriate for longitudinal study design were
performed separately for the binary IUGR outcome and the continuous EFW outcome using
formulas proposed by Diggle et al132 and Twisk,133 respectively. The following assumptions
were made for both power calculations. A fixed sample size of 177 women, an average of 4
follow-up visits, a correlation between repeated IUGR (or EFW) measurements of 0.23
(obtained from the correlation matrix obtained using generalized estimating equations), and
alpha equal to 0.05.
For the binary IUGR outcome, we additionally assumed an estimated risk of IUGR in the
unexposed of 0.11 based on data from our sample. Under these assumptions, we have 80%
power to detect a RR comparing fetuses exposed and unexposed to malaria of
approximately 1.9.
For the continuous EFW outcome, we additionally assumed a ratio of malaria exposed to
unexposed women of 0.13 and an average standard deviation of EFW of 500 grams. Under
these assumptions, we have 80% power to detect a difference of 202 grams between
fetuses exposed and unexposed to malaria.
Sensitivity analyses: We undertook a sensitivity analyses to test the robustness of the RR
associations identified in this analysis. We aimed to identify how much the RR and 95%
confidence intervals for malaria and under-nutrition would change based on a different
definition of IUGR. To do this, we re-analyzed the data using a fetal size nomogram
developed specifically from the Congo data (Specific Aim 2) to define IUGR. Details of this
analysis can be found in Chapter 5.
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Analyses for Specific Aim 2: Utilize prospectively collected ultrasound data to develop a fetal
size for gestational age nomogram for a resource poor population with high malaria
prevalence
Study population: A total of 182 women participated in the longitudinal study. Two sets of
exclusions were made for this analysis (Figure 2.3). First, three stillbirth outcomes were
excluded. Next, women who did not have a certain gestational date (defined as LMP date
within ±14 days of the ultrasound derived gestational date) were excluded. Of the 182
women enrolled in the study, 151 provided a complete LMP date at enrollment (day, month,
year). Of these 151 women, 127 had an ultrasound confirmed LMP date and were included
in the analysis. Of the 24 excluded women, nine had an LMP that was <14 days from
ultrasound date and 15 had an LMP that was >14 days from the ultrasound date. For the 28
women who did not supply a complete LMP date, we asked them to estimate how many
weeks had elapsed since their LMP. Using this information, we imputed an LMP date by
multiplying the number of elapsed weeks by seven and subtracting the resultant number of
days from the date in which the women was interviewed.
Figure 2.3. Flowchart of exclusion and inclusion criteria for Specific Aim 2
182 women enrolled in
longitudinal study 3 Stillbirths
151 provided a full
LMP date
28 LMP date
imputed
24 LMP NOT
confirmed by US
17 LMP
confirmed by US
127 LMP
confirmed by US
11 LMP NOT
confirmed by US
144 women with LMP date
confirmed by ultrasound
included in analysis
43
Of these 28 women, 17 had an ultrasound confirmed LMP date and were included in the
analysis. Of the 11 excluded women, seven had an LMP that was <14 days from the
ultrasound date and 4 had an LMP that was >14 days from the ultrasound date. Thus, the
final study sample comprised 144 singleton pregnancies and 755 ultrasound scans. The
average number of scan per fetus was four (SD=1) and the average duration between scans
was 29 days (SD=4 days). 
 Initial exploratory analyses were conducted to describe the fetal growth pattern for each
woman individually. This helped to provide an idea of the shape of the growth curve in this
population and informed which transformations of the estimated fetal weight variable might
be needed to achieve good model fit for these data. As well, the distribution of the outcome
variable (EFW) at each gestational age was explored to assess normality and variance.
Statistical analysis: In longitudinal studies, the observations collected on one subject over
time (often called nested within a subject) are highly correlated. Because of this, some
researchers have suggested that reference intervals of fetal size be based on cross-
sectional data in which each fetus contributes only a single value to the reference sample.118
However, advanced statistical techniques, such as the mixed effect model approach used in
this analysis, account for the high correlation in longitudinal studies making it possible to
utilizing longitudinal data to create a size nomogram (see Appendix B for a detailed overview
of the mixed effect model).133
For this analysis, we created a fetal size nomogram from longitudinal ultrasound data
using the mixed effects model approach for calculating reference intervals suggested by
Royston.125 As a first step, estimated fetal weight (the dependent variable) was log-
transformed to ensure normality and reduce heteroscedasticity of the dependent variable
residuals. Secondly, gestational age (the independent variable) was modeled using a best
fitting second degree fractional polynomial linearizing function.134 A fractional polynomial is a
linear combination that allows for non-negative, negative and fractional powers of a variable
44
(in this case time T). Fractional polynomials are a general class of functions that can capture
a variety of shapes to find the “best fit” of the independent variable. A second degree
fractional polynomial has the form:
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The SAS procedure PROC MIXED was used to fit a linear mixed effect growth curve for
each fetus, which specified both fixed effects and random effects for the intercept and
linearized time variable. If ijZ represents the log-transformed estimated fetal weight
and ijX represents the factional polynomial transformation of time, then the mean ( )ijμ and
variance 2( )ijσ of ijZ at transformed time ijX are:
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The reference intervals for the untransformed estimated fetal weights, iY were calculated
from the mean and variance above as exp( )ij ijµ ± where ij is the standard error of
ijZ and  is the standard distribution function (±1.96 for the 2.5th and 97.5th centile, ±1.645
for the 5th and 95th centiles, ±1.282 for the 10th and 90th centiles, and ±0.674 for the 25th and
75th centiles, and 0 for the 50th centile).
Influence diagnostics: In simple linear regression, influential observations are defined as
observations in the data set that appear to have a large influence on the parameter
estimates. After the model is fitted, residuals are calculated as the actual value of the
response variable minus the model predicted value. The general idea behind influence
diagnostics is to quantify the influence of one (or more) observations on the parameter
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estimates. This is done by removing each observation from the dataset, refitting the model,
and computing statistics based on the change between the full-data and reduced-data
estimation. In the case of mixed effect models, an additional level of “influence” must be
taken into consideration. Observations can impact not only the fixed effects but also the
covariance parameter estimates on which the fixed effects estimates depend.135
The mixed effect model described above was fitted using all 144 women eligible for this
analysis. Influence diagnostics which iteratively removed each participant from the model
were use to identify fetuses who influenced the estimates of the fixed effects and/or precision
of the variance and covariance portions of the model. Appendix D provides detailed
information about the various influence statistics analyzed as well as tabular and graphical
representations of the influence diagnostics for each participant.
As judged by the restricted likelihood distance and the Cook’s D statistics, two participants
(ID numbers 7192 and 7403) appeared to have the greatest influence on the overall
analysis. These participants also influenced the precision of the covariance parameters, as
evidenced by a low COVRATIO and high COVTRACE values.
After identifying these two participants as potential influential observations, the model was
refitted excluding these ID numbers (n=142). This exclusion did slightly improve the normality
of the residuals; however, it had very little effect on the parameter estimates (or their
standard errors) for the fixed and random portions of the model (Table 2.2).  
 Accordingly, we found that removing these observations had very little effect on the final
mean and percentile values obtained from the model. For example, the difference between
the 10th centile values before and after removing the two influential observations were 0
grams for weeks 15 to 23, less than 10 grams for weeks 23 to 30 and 12 to 40 grams from
weeks 34 to 40. Thus, we decided to retain those observations in the model and move
forward with the full data set of 144 women.
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Table 2.2. Beta coefficients and standard errors for the fixed and random components
of the model before the after removal of two influential observations
Full model Model after removinginfluential observations
Parameter Estimate Standard
Error
Estimate Standard
Error
Fixed effects
0 j -0.1195 0.02563 -0.1224 0.02445
1 j 1.0213 0.00404 1.0217 0.00377
Random effects
2
0 j
 0.04519 0.01158 0.03592 0.01048
2
1 j
 0.00132 0.00022 0.00100 0.00025
jj 10 ,
 -0.00761 0.00180 -0.00588 0.00159
2
error 0.00338 0.00022 0.00335 0.00022
Residual analysis: The mixed effect models used in this analysis are part of the family of
generalized linear models, and thus are subject to the statistical assumptions that residual
errors are normally distributed with mean zero and a constant variance (homoscadastic). To
assess these assumptions, raw and studentized residual errors of the log-transformed
outcome were visually inspected by various plots (Figures 2.4 and 2.5). The studentized
residuals are the usual residuals divided by their standard errors and always have a mean
value of zero. Normality of the errors was determined by visual inspection of normality plots
(top right panel shows a histogram of the residuals with Normal density overlay and the
bottom left panel shows a Q-Q plot). The data display a normal pattern as evidenced by both
plots, with the majority of data falling along the diagonal line of the Q-Q plot. Variance of the
errors can be assessed by the scatter plot (top left panel of the figures). The assumption of
homoscadasticity also appears to be met as the residuals are spread evenly above and
below zero on the plots (constant spread).
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Figure 2.4. Raw residuals for the final mixed effect model
Figure 2.5. Studentized residuals for the final mixed effect model
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Comparison with nomograms from industrialized populations: As a final analytic step, we
compared our derived reference intervals to nomograms from three industrialized
populations (the United States, the United Kingdom and Norway). To compare the 10th, 50th,
and 90th percentiles at each gestational age, we calculated the percent difference in
estimated fetal weight between the industrialized reference values and the Congo nomogram
value as: Re Re[( / ) 100]ference Congo ferenceEFW EFW EFW  . These percent differences were then
plotted against gestational age to provide a visual representation of the differences between
the curves. Percent differences greater than zero represent a higher EFW value in the
industrialized reference compared to the value from the Congo nomogram (overestimation)
while percent differences below zero represent lower EFW values in the industrialized
nomogram (underestimation).
Sensitivity analysis of the Hadlock formula for estimated fetal weight calculation: Because
fetal weight estimation is an important component of a fetal size nomogram, we wanted to
explore how the use of another EFW algorithm would affect the centile values of the fetal
size nomogram developed for Congo. We re-ran the data analysis and created a new
nomogram based upon EFW calculated using the algorithm proposed by Shepard which
utilizes two biometric parameters, AC and BPD [log(EFW)= -1.7492 + 0.166*BPD +
0.046*AC - 0.002646*BPD*AC].136 This formula has been shown to have low systematic and
random error in the estimation of fetal weight. Details regarding this sensitivity analysis can
be found in Appendix E.
CHAPTER 3:
IMPACT OF MATERNAL MALARIA AND UNDER-NUTRITION ON INTRAUTERINE
GROWTH RESTRICTION: A PROSPECTIVE COHORT STUDY IN DEMOCRATIC
REPUBLIC OF CONGO
ABSTRACT
Maternal malaria and under-nutrition are established risk factors for small for gestational
age (SGA) at delivery; however, a study to investigate their effects on intrauterine growth
restriction (IUGR) has never been performed. The authors conducted a prospective,
longitudinal ultrasound study of 182 pregnant women in Kinshasa, Democratic Republic of
Congo from May 2005 through May 2006. At monthly intervals, malaria infection, maternal
anthropometrics, and ultrasound estimated fetal weight were measured. All positive malaria
cases were treated and intermittent presumptive therapy with sulphadoxine-pyrimethamine
was provided. IUGR was defined as estimated fetal weight below the 10th percentile of a
standardized fetal weight curve. Log-binomial models were fitted separately for malaria and
maternal anthropometric exposures, accounting for statistical clustering due to repeat IUGR
measurements. Variation in the relationship between malaria and IUGR by under-nutrition
was also examined. Incident malaria infection was not significantly associated with an
increased risk of IUGR (Risk ratio (RR)=1.2, 95% confidence interval (CI): 0.7, 2.2). The risk
of IUGR associated with malaria infection was 2 to 7-fold higher among women with poor
nutrition. Frequent monitoring and case management of antenatal malaria infections may
prevent IUGR, suggesting that antenatal malaria screening policies and nutrient
supplementation in malaria endemic areas should be bolstered.
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INTRODUCTION
Each year, over 20 million infants worldwide are born with low birth weight (LBW), placing
them at significantly increased risk of neonatal mortality and other childhood morbidities.137
The major contributor of LBW in resource poor settings is small-for-gestational-age at
delivery (SGA).1,15,138 Although some SGA is constitutionally (genetically) determined, most
results from intrauterine growth restriction (IUGR), an underlying pathological condition
characterized by insufficient transfer of nutrients and oxygen to the fetus and impaired
growth of fetal organs and tissues. IUGR may result from limited availability of maternal
micro- and macro-nutrients (maternal under-nutrition), or from medical conditions, including
hypertension or infection, that impede proper vascularization of the placenta and restrict the
transfer of essential nutrients from mother to fetus.15,16,139
In resource poor settings such as sub-Saharan Africa, pregnant women are frequently
under-nourished and at increased risk of malaria infection, making them particularly
vulnerable to delivering an SGA infant. Malaria infection28,30, 54,140,141,142,143 and maternal
anthropometric indicators of under-nutrition, including short stature,15,80 low pre-pregnancy
weight80,144 or body mass index (BMI),15,145 inadequate pregnancy weight gain,97,146 and low
maternal upper arm fat mass15 are independently associated with an increased risk of SGA
at delivery.
To date, studies of fetal growth in sub-Saharan Africa have been limited to describing the
size of the fetus at birth (SGA). Studies describing in utero fetal growth are limited, due
largely to a lack of ultrasound resources necessary to diagnose IUGR. The objective of this
study was to prospectively describe IUGR in an urban, low-income African population to
assess the unique and combined effects of maternal malaria and under-nutrition on the risk
of IUGR.
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MATERIALS AND METHODS
Study population and recruitment
This prospective longitudinal cohort study was conducted between May 2005 and May
2006 among pregnant women seeking antenatal care at Binza Maternity Hospital in
Kinshasa, Democratic Republic of Congo. Binza Maternity Hospital is one of the oldest
maternities in Kinshasa and serves a predominately urban population. During routine
antenatal registration, all women identified as aged 18 years old with a fundal height or last
menstrual period derived gestational age of <23 weeks were invited to receive an ultrasound
examination to confirm gestational age. All women with an ultrasound confirmed gestational
age 22 weeks were invited to participate in the longitudinal study. Women with high blood
pressure at baseline (systolic >140 mmHg and/or diastolic >90 mmHg), multiple gestations,
or a detectable fetal abnormality were excluded. All enrolled women participated in an
existing HIV voluntary counseling and testing program at Binza Maternity Hospital. Written
informed consent was obtained for all participants, and the protocol was approved by the
Institutional Review Boards at the University of North Carolina, Chapel Hill and the University
of Kinshasa.
Baseline and follow-up visits
During a baseline interview, sociodemographic characteristics, alcohol, tobacco and drug
use, medical and obstetric history, malaria symptoms, and current use of anti-malarial drugs
were collected. Using standard techniques,128 maternal weight was measured to the nearest
0.1 kilogram (SECA digital scale Model 890), and maternal height (without footwear or head
cover) and mid upper arm circumference (MUAC) to the nearest 0.1 cm. Blood pressure and
body temperature were recorded and a malaria thick smear and hematocrit were prepared
from a finger-prick blood sample. All women received an insecticide treated bed net.
Participants returned for monthly follow-up visits until delivery during which the ultrasound
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examination and the medical and laboratory examinations (including malaria thick smears)
were repeated. In accordance with Congolese National Policy, presumptive therapy with
sulfadoxine-pyrimethamine (SP) was provided to all women between 16-27 weeks and 28-32
weeks gestation, regardless of malaria status. In addition, all women with positive
parasitemia were treated; SP was the first line treatment; however, quinine, artesunate or
camoquine was prescribed if the women had received SP within the preceding month.
Women were instructed to return to the maternity hospital between follow-up visits if they
experienced any pregnancy complications or symptoms of malaria. At these visits, a malaria
thick smear was prepared and medical care was provided by Binza Maternity’s outpatient
clinic staff.
Ultrasound measurements
Fetal biometric measurement of the biparietal diameter (BPD), head circumference (HC),
abdominal circumference (AC), and femur length (FL) were taken to estimate gestational age
and fetal weight. In the first trimester (gestational age <14 weeks), crown-rump length was
used to estimate gestational age. All ultrasounds were performed by a single
ultrasonographer using a GE Logiqbook System. HC and BPD were measured using
standard techniques.147 BPD was measured by placing the calipers from leading edge to
leading edge (outer to inner skull) and HC using an ellipse trace of the outline of the fetal
head. AC was measured where the junction of the umbilical vein and portal sinus was
visible. The ellipse function was used to trace the extreme perimeter of the fetal abdomen.
FL was measured along the long axis of the femur from outer to outer margin, including the
femoral diaphysis and excluding the epiphyses. Gestational age in weeks and days (first
ultrasound scan only) and estimated fetal weight in grams (all ultrasound scans) were
calculated using formulas proposed by Hadlock.126,27
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Laboratory methods
A single microscopist read all malaria thick smears on site during study visits. Smears
were stained with Giemsa and read counting the number of asexual parasites against 200
white blood cells and converted to numbers of parasites per µl under the assumption that
there were 6000 white blood cells per µl. Anemia was assessed from finger-prick blood
samples and the percent hematocrit was recorded (Clay Adams, Readacrit).
Quality control
For quality assurance, a 10% sample of all malaria thick smears was assessed
independently by a second laboratory technician. Of 140 slides examined, there was one
discordant positive and one discordant negative between the two technicians (sensitivity:
92%, specificity: 99%). In a similar fashion, a 10% sample of ultrasound images was
assessed for quality by a maternal-fetal medicine physician at the University of North
Carolina, Chapel Hill. Ninety-two percent of reviewed images were deemed adequate for
clinical assessment; 7% of questionable quality and 1% poor quality (i.e., not all biometry
landmarks clearly visible, shadowing in the image, or poor tracing of the length of
circumference).
Definitions
IUGR was defined as a binary outcome of <10th percentile of fetal weight for attained
gestational age using the Hadlock fetal weight nomogram.129 Socioeconomic status (SES)
was defined as a composite variable, with those who were currently employed (participant or
her partner) and living in a home with toilet facilities, a nearby water source, and electricity
characterized as high SES. Anemia was defined as a time-dependent hematocrit of <30%.
The “malaria parasitemia at visit” variable represents a time-dependent measure of an
incident antenatal infection that began during the interval between a woman’s previous
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visit and the study visit in which the IUGR measurement was obtained. The “cumulative
positive parasitemia” variable represents a time-dependent measure of the number of
times that a woman had a positive smear up to and including that visit. Short stature was
defined as height <150 cm. Maternal weight and height at enrollment were used to
calculate baseline body-mass index (BMI), with low BMI defined as <19.8 kg/m2. Change
in MUAC during pregnancy was dichotomized as loss (<0 cm change) versus no change
or gain (0 cm change), over three distinct periods: (i) monthly change between study
visits; (ii) change over the entire second trimester; and (iii) change over the entire third
trimester. Change in maternal weight was calculated between each monthly visit, and
categorized as low (<1.5 kg) or adequate (1.5 kg) monthly weight gain.
Statistical methods
All analyses were performed in SAS, version 8.2 (SAS, Cary, NC). Log-binomial
regression models were fitted to estimate risk ratio (RR) and 95% confidence intervals
(CI) for IUGR before and after adjusting for potential confounders. To account for repeat
outcome measures over the course of pregnancy, the regression models were estimated
based on the method of generalized estimating equations with an exchangeable working
correlation structure.130 Owing to reduced variability in fetal weight during the first
trimester, IUGR is not typically seen until the second trimester; we therefore left-
truncated all person-time at 22 weeks gestation, resulting in 758 IUGR measurements
available for analysis.
We discovered a malfunction in the scale used to weigh mothers that affected
measurements taken during a three to four week period. All suspect data points were
removed before calculation of the weight gain variable leaving 588 visits with complete
data for all covariates. A second set of log-binomial models was fitted for these 588 visits;
the distribution of maternal socio-demographics, under-nutrition, malaria status, and
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gestational age of IUGR for the excluded visits were similar to those of the entire study
population (data not shown).
Models were fitted separately for the incident and cumulative malaria exposure
variables and for several maternal anthropometric indicators of under-nutrition. As there
is evidence that maternal weight gain and MUAC may have differential fetal effects
depending on pre-pregnancy nutritional status and timing during pregnancy,73,102 models
for these exposures were stratified for baseline BMI status and trimester of pregnancy,
respectively.
To evaluate potential interaction between maternal malaria infection and under-
nutrition on the risk of IUGR, an interaction term for malaria and each anthropometric
indicator was added to the models. A P-value of <0.15 for the interaction term was
considered significant. For all analyses, maternal age, SES, and gravidity were assessed
as confounders using a backward elimination procedure with 10% change in estimate
criterion; additionally maternal nutritional factors were assessed as confounders in
malaria exposure models.
RESULTS
Recruitment and follow-up
Of 1,111 new antenatal care attendees, 33% (n=370) met all initial screening criteria and
were scanned to determine gestational age. Of those, 182 were eligible and consented to
the longitudinal study (reasons for ineligibility included: absent for dating ultrasound (n=24);
twin pregnancy (n=6); no viable fetus present (n=4); and gestational age greater than 22
weeks (n=154)). Five HIV-positive women (3%) were excluded from all analyses for a final
sample size of 177 women. These 177 women completed a total of 1,120 study visits. On
average, women received five ultrasound scans (range two to eight). One maternal death
and one loss to follow-up occurred before delivery. Mean gestational age at enrollment was
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18 weeks (standard deviation (SD)=3).
Antenatal malaria
Of 1,120 thick smears, 14% (n=157) were incident positive malaria infections. (Fourteen
probable recrudescent episodes that occurred within 14 days of a previous positive, despite
receiving treatment, were excluded from analysis). Sixty percent of women had at least one
positive smear during follow-up: 38% had a single incident infection, 15% had two incident
infections, and 8% were infected three or more times. Baseline malaria prevalence was 27%
and generally declined with increasing gestational age (Figure 3.1). The majority of infections
were P. falciparum (98%). The parasite density ranged from 29 to 13,380 with a mean of 525
(SD 1,734) parasites per µl.
Maternal under-nutrition
At baseline, mean BMI was 23.7 kg/m2 (SD 3.6). Eleven percent of women were
underweight (BMI <19.8 kg/m2), 66% were normal weight (19.8-26 kg/m2), 14% overweight
(26-29 kg/m2) and 8% obese ( 30 kg/m2). Three percent of women had short stature (mean
height 161.4 cm, SD 6.6). Mean monthly weight gain was 1.6 kg (SD 1.5). Participants
generally gained more upper arm fat during the second trimester (mean 0.2 cm, SD 0.8) than
the third trimester (mean 0.1 cm, SD 0.8).
IUGR
IUGR was measured at the 758 visits after 22 weeks gestation. A total of 52 fetuses
(29%) experienced 76 episodes of IUGR. Of these, 17% were IUGR at only one scan,
8% were IUGR at two scans and 4% at three or more ultrasound scans. Eighty two
percent of the IUGR episodes occurred in the third trimester, with peak prevalence
between 28 and 33 weeks gestation. Receiving antimalarial treatment at the previous
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visit was significantly associated with a reduced risk of IUGR (RR=0.5, 95% CI: 0.3, 0.7).
Maternal anemia, younger (18-24) and older (30) maternal age and low gravidity were
not associated with IUGR in unadjusted analyses (Table 3.1).
IUGR and malaria
We observed no significant effect of a single incident malaria infection on IUGR either in
the unadjusted analysis (RR=1.2, 95% CI: 0.7, 2.2) or after adjustment for maternal age and
weight gain in the past month (RR=1.6, 95% CI: 0.9, 2.8) (Table 3.2). Compared to fetuses
with no antenatal malaria exposure, a three-fold increase in the risk of IUGR was observed
among women infected three or more times throughout pregnancy, despite treatment
(RR=3.3, 95% CI: 1.3, 8.2).
IUGR and under-nutrition
Associations between anthropometric indicators of under-nutrition and IUGR are shown in
Tables 3.3 and 3.4. Inadequate maternal weight gain (defined as <1.5 kg per month) was
more strongly associated with an increased risk of IUGR in women with low baseline BMI
(RR=2.7, 95% CI: 0.9, 8.5) compared to women with adequate baseline BMI (RR=1.4, 95%
CI: 0.9, 2.2). Associations between MUAC loss and IUGR varied by trimester (Table 4), with
increased risk seen in the second (RR=2.7, 95% CI: 1.0, 7.7), but not in the third trimester
(RR=1.1, 95% CI: 0.6, 1.9). Similarly, low monthly weight gain during the second trimester
(RR=5.7, 95% CI: 1.3, 25.0), but not the third (RR=1.1, 95% CI: 0.7, 1.7) was significantly
associated with an increased risk of IUGR.
Combined effects of malaria and under-nutrition on IUGR
A detrimental effect of malaria infection on IUGR risk was significantly stronger among
under-nourished women (Table 3.5), regardless of which anthropometric indicator was
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examined. For example, among women with low baseline BMI, an incident malaria infection
increased the risk of IUGR over four-fold (RR=4.5, 95% CI: 1.0, 19.9) compared to those
unexposed to malaria. However, at normal baseline BMI levels, there was no observed
association between malaria and IUGR (RR=1.1, 95%CI: 0.6, 2.1). A similar pattern was
seen among shorter women, women with monthly MUAC loss, and women with low monthly
weight gain. Analyses of cumulative malaria resulted in a similar pattern, with the joint effect
of low baseline BMI and cumulative malaria associated with the largest risk (RR=7.0, 95%
CI: 3.2, 15.3).
DISCUSSION
A longitudinal study of IUGR has never previously been carried out in a malaria-endemic
area. We measured fetal growth in utero and identified IUGR in nearly a third of fetuses in
this urban, sub-Saharan Africa population. This analysis focused on two component causes
of IUGR that have heightened relevance in resource poor settings, malaria infection and
maternal under-nutrition. In this Congolese population, we found that malaria infection alone
was only modestly associated with an increased risk of IUGR, and that a significant
independent effect of malaria was seen only among women with three or more incident
infections during gestation. We also found that the effect of maternal malaria varied
significantly by maternal nutritional status, and that the highest risks of IUGR were evident
among the most under-nourished women.
Antenatal malaria may lead to IUGR through accumulation of P. falciparum infected
erythrocytes, and immunity related monocytes and pro-inflammatory cytokines in the
placental intervillious space. Hemozoin, a byproduct of parasite hemoglobin digestion, can
also be found in phagocytic leucocytes and within fibrin deposits in the intervillous space.12
This build-up can lead to thickening of the trophoblast basement membrane and effect
uteroplacental arterial development, thus decreasing maternal-fetal nutrient exchange.42,45
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Previous studies conducted in areas of high P. falciparum transmission have consistently
reported associations between SGA and both antenatal30,54,140 and placental malaria
infection.30,54,140,141,142
Our findings are at variance with these earlier studies, with differences most likely
stemming from the fact that we screened for malaria at monthly intervals and treated all
positive antenatal parasitemia. Further, virtually all women received two presumptive doses
of SP. Routine screening and treatment may have eliminated parasites before they had
adequate time to sequester in the placenta and cause damage to the placental vasculature,
potentially minimizing the effect of malaria infection. In this study, treatment was
independently protective against both incident malaria infection and IUGR, and led to higher
attained fetal weight (data not shown), further supporting this hypothesis. Our findings are
consistent with two studies of low malaria transmission areas (the Thai-Burmese border and
highlands of Ethiopia) that also had frequent monitoring and treatment of antenatal
parasitemia.148,149 Collectively, these findings suggest that even in areas of high malaria
transmission, prompt identification and treatment of sub-clinical malaria infections may
prevent fetal growth restriction from occurring.
Maternal under-nutrition was both an independent risk factor for IUGR and a significant
modifier of the association between malaria and IUGR. Chronic pre-pregnancy under-
nutrition, low weight gain and inadequate accumulation of fat stores during pregnancy can
render a woman incapable of meeting the substantial metabolic demands of pregnancy.8
The mean monthly weight gain of 1.6 kg for these Congolese women was similar to weight
gain reported in other resource poor settings.70 As suggested in previous studies, we found
that maternal weight gain was more strongly associated with IUGR in women with low
baseline BMI, 102,146 and that low weight gain in the second trimester increased IUGR risk.93,96
Our data also corroborate previous findings that failure to accrue arm fat during the second
trimester, but not the third trimester, is associated with lower fetal weight.73
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The association between malaria and IUGR was consistently two- to seven-fold higher
among women with evidence of under-nutrition. In resource poor settings, it has long been
recognized that childhood malnutrition and attendant sequellae influence susceptibility to and
severity of malaria infection.31 Repercussions of childhood under-nutrition and malaria
infection, such as stunting and low BMI, place pregnant women at increased risk of poor
birth outcomes. Further, the joint effects of adult under-nutrition and malaria infection may
act on similar physiologic pathways to reduce uteroplacental blood flow8 and decrease
maternal-fetal oxygen transfer.34
Limitations and strengths
Although malaria and under-nutrition are common causes of IUGR, other risk factors, such
as chromosomal abnormalities, preeclampsia or substance use may have played a role. We
attempted to minimize the effects of other medical factors through our exclusion criteria and
found that reported tobacco, alcohol and drug use were minimal. The extent to which fetuses
in our cohort were constitutionally small-for-age versus truly pathological IUGR cases
remains unknown, thereby leading to the possibility of some misclassification of IUGR.
Moreover, our IUGR definition utilized a fetal weight-for-age nomogram created from an
industrialized country, which may have overestimated the proportion of IUGR fetuses in this
resource poor population. We may have also overestimated true pre-pregnancy weight by
using maternal weight at enrollment as a proxy; however, any resultant bias is likely minimal
because participants were enrolled early in pregnancy, before women in resource poor
settings tend to gain significant pregnancy weight.70 Lastly, this study was designed as a
pilot to prepare laboratory, ultrasound and clinical operating procedures for a larger
subsequent trial, and thus the sample size was selected for convenience, rather than to
maximize power. A larger longitudinal study to replicate these findings is warranted.
Despite these limitations, our findings suggest that active antenatal screening and
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effective treatment of maternal malaria infections, regardless of symptoms, may reduce the
prevalence of IUGR and consequently the burden of infant mortality. The heightened risk of
IUGR seen among women who were both under-nourished and malaria-infected
underscores the importance of incorporating maternal anthropometric screening and
nutritional supplementation into routine antenatal care in malaria endemic areas.
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Figure 3.1. Prevalence of parasitemia by gestational age, Kinshasa, Democratic
Republic of Congo, 2005-2006
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Table 3.1. Baseline and visit-specific characteristics of pregnant women
and risk ratios (RR) and 95% confidence intervals (CI) for IUGR, Kinshasa,
Democratic Republic of Congo, 2005-2006
Percent* RR† 95% CI
Maternal age (years)
18-24 32% 1.7 0.8, 3.4
25-29 32% 1.0 Ref
30 36% 1.4 0.7, 2.9
Socioeconomic status
High 14% 1.1 0.5, 2.4
Low 86% 1.0 Ref
Gravida
1-2 41% 1.5 0.8, 2.6
3 59% 1.0 Ref
Fetal gender
Male 47% 0.6 0.3, 1.0
Female 53% 1.0 Ref
Treated in previous month
Yes 49% 0.5 0.3, 0.7
No 51% 1.0 Ref
Hematocrit at visit
<30 11% 0.9 0.4, 2.1
30 89% 1.0 Ref
* Maternal age, socioeconomic status and gravidity recorded at baseline only (n=177);
treatment recorded at baseline and each follow-up visit (n=758); hematocrit recorded at baseline and
every other follow-up visit (n=388).
† Unadjusted. Model included 758 study visits and 76 episodes of IUGR.
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Table 3.2. Risk ratios (RR) and 95% confidence intervals (CI) for the association between IUGR and
incident and cumulative malaria infection, Kinshasa, Democratic Republic of Congo, 2005-2006
Percent* RR† 95% CI RR‡ 95% CI RR§ 95% CI
Malaria parasitemia at visit
Positive 11% 1.2 0.7, 2.2 1.2 0.7, 2.2 1.6 0.9, 2.8
Negative 89% 1.0 Ref 1.0 Ref 1.0 Ref
Cumulative malaria
parasitemia up to visit
0 52% 1.0 Ref 1.0 Ref 1.0 Ref
1 34% 0.9 0.5, 1.7 0.9 0.5, 1.6 0.8 0.4, 1.5
2 10% 1.2 0.5, 2.6 1.2 0.5, 2.6 1.6 0.8, 3.3
3 4% 2.4 0.9, 6.5 2.3 0.8, 6.3 3.3 1.3, 8.2
PTrend = 0.31 PTrend = 0.33 PTrend = 0.11
Cumulative malaria
parasitemia up to visit
2 positive
<2 positive
14%
86%
1.5
1.0
0.8, 2.9
Ref
1.5
1.0
0.8, 2.8
Ref
2.1
1.0
1.2, 3.6
Ref
3 positive
<3 positive
4%
96%
2.4
1.0
0.9, 6.3
Ref
2.3
1.0
0.9, 6.0
Ref
3.2
1.0
1.3, 7.7
Ref
* Malaria status recorded at baseline and each follow-up visit (n=758).
† Unadjusted. Model included 758 study visits and 76 episodes of IUGR.
‡ Adjusted for age. Model included 758 study visits and 76 episodes of IUGR.
§ Adjusted for age and weight gain. Model included 588 visits with complete data for weight gain and 66 episodes of IUGR.
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Table 3.3. Risk ratios (RR) and 95% confidence intervals (CI) for the association between IUGR
and maternal anthropometric indicators, Kinshasa, Democratic Republic of Congo, 2005-2006
Percent* RR† 95% CI RR‡ 95% CI RR§ 95% CI
Time-independent variables
Baseline BMI
<19.8 kg/m2
19.8 kg/m2
11%
89%
1.1
1.0
0.6, 2.2
Ref
1.0
1.0
0.5, 2.0
Ref
1.0
1.0
0.5, 2.0
Ref
Short stature
<150 cm
150 cm
3%
97%
1.5
1.0
0.4, 5.4
Ref
1.4
1.0
0.4, 4.7
Ref
1.7
1.0
0.5, 5.5
Ref
Time-dependent variables
MUAC change per month #
Baseline BMI <19.8 kg/m2
Baseline BMI 19.8 kg/m2
11%
89%
1.5
1.0
0.5, 4.2
0.7, 1.5
1.5
1.0
0.5, 4.2
0.7, 1.5
1.1
0.9
0.3, 3.6
0.6, 1.4
Maternal weight gain per
month**
Baseline BMI <19.8 kg/m2
Baseline BMI 19.8 kg/m2
13%
87%
2.7
1.3
0.9, 8.5
0.8, 2.0
--
--
--
--
2.7
1.4
0.9, 8.5
0.9, 2.2
* Baseline BMI and height recorded at baseline only (n=177); MUAC data reflects percent of women with MUAC change <0 cm
at each level of BMI (n=711 visits); weight gain data reflects percent of women with <1.5 kg of weight gain per month at each level
of BMI (n=588 visits).
† Unadjusted. Model included 758 study visits and 76 episodes of IUGR for BMI, stature, and MUAC; 588 visits and 66 episodes of
IUGR for weight gain.
‡ Adjusted for age. Model included 758 study visits and 76 episodes of IUGR.
§ Adjusted for age. Model included 588 visits with complete data for weight gain and 66 episodes of IUGR.
# Comparing MUAC change in the previous month of <0 cm vs. 0 cm.
** Comparing maternal weight gain in the previous month of <1.5 kg per month vs. 1.5 kg per month.
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Table 3.4. Trimester specific risk ratios (RR) and 95% confidence intervals (CI) for the association
between IUGR and change in MUAC and weight gain, Kinshasa, Democratic Republic of Congo, 2005-2006
IUGR in second
trimester
IUGR in third
trimester
RR* 95% CI RR† 95% CI
MUAC change*
Over entire 2nd trimester 2.7 1.0, 7.7 -- --
Over entire 3rd trimester -- -- 1.1 0.6, 1.9
Weight gain per month†
Second trimester 5.7 1.3, 25.0 -- --
Third trimester -- -- 1.1 0.7, 1.7
* Unadjusted. Models included 217 study visits and 14 episodes of IUGR in the second trimester and 526 study visits
and 62 episodes of IUGR in the third trimester. Comparing MUAC change over the whole trimester of < 0 cm vs.  0 cm.
† Unadjusted. Models included 160 study visits and 12 episodes of IUGR in the second trimester and 428 study visits
and 54 episodes of IUGR in the third trimester. Comparing maternal weight gain in the previous month of <1.5 kg per month
vs. 1.5 kg.
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Table 3.5. Risk ratios (RR) and 95% confidence intervals (CI) for the association between IUGR and
malaria, stratified by maternal anthropometrics, Kinshasa, Democratic Republic of Congo, 2005-2006
RR* 95% CI RR† 95% CI RR‡ 95% CI
Malaria parasitemia at visit
(Positive vs. negative)
Baseline BMI <19.8 kg/m2
Baseline BMI 19.8 kg/m2
4.8
0.8
2.0, 12.1
0.4, 1.7
4.9
0.8
2.0, 11.9
0.4, 1.7
7.0
0.9
2.9, 17.1
0.4, 1.8
Height <150 cm
Height 150 cm
5.1
1.1
1.1, 22.9
0.6, 2.1
4.5
1.1
1.0, 19.9
0.6, 2.1
3.3
1.3
0.8, 13.8
0.7, 2.5
MUAC gain <0 cm in past month
MUAC gain 0 cm in past month
2.4
0.5
1.2, 5.0
0.1,1.9
2.4
0.5
1.2, 5.0
0.1,1.9
3.2
0.3
1.8, 5.9
0.1,1.5
Weight gain <1.5 kg in past month
Weight gain 1.5 kg in past month
1.7
1.4
0.8, 3.6
0.6, 3.0
--
--
--
--
1.8
1.4
0.9, 3.8
0.6, 3.0
Cumulative malaria parasitemia
( 2 positive vs. < 2 positive)
Baseline BMI <19.8 kg/m2
Baseline BMI 19.8 kg/m2
7.3
1.1
3.3, 15.9
0.5, 2.3
7.0
1.1
3.2, 15.3
0.5, 2.3
9.2
1.3
4.1, 20.7
0.6, 2.9
Height <150 cm
Height 150 cm
2.1
1.5
0.2, 24.3
0.7, 2.9
2.6
1.4
0.4,19.2
0.7, 2.8
2.0
1.9
0.3,12.8
1.0, 3.6
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Table 3.5., continued
RR* 95% CI RR† 95% CI RR‡ 95% CI
MUAC gain <0 cm in past month
MUAC gain 0 cm in past month
2.0
1.1
0.9, 4.3
0.5, 2.5
2.0
1.1
0.9, 4.4
0.5, 2.4
3.2
1.3
1.5, 6.7
0.5, 3.0
Weight gain <1.5 kg in past month
Weight gain 1.5 kg in past month
2.4
1.7
1.2, 4.5
0.8, 4.0
--
--
--
--
2.3
1.8
1.3, 4.3
0.8, 4.0
* Unadjusted. Model included 758 study visits and 76 episodes of IUGR for BMI, stature, and MUAC; 588 visits and 66 episodes of
IUGR for weight gain.
† Adjusted for age. Model included 758 study visits and 76 episodes of IUGR.
‡ Adjusted for age. Model included 588 visits with complete data for weight gain and 66 episodes of IUGR.
Note: RR pairs highlighted in bold indicate a significant P-value for the interaction term between malaria and the anthropometric
indicator (P-value < 0.15).
CHAPTER 4:
AN ULTRASOUND DERIVED FETAL SIZE NOMOGRAM FOR A
SUB-SAHARAN AFRICAN POPULATION: A LONGITUDINAL STUDY
ABSTRACT
We created a fetal size nomogram for use in low resource settings and compared the
derived centiles to reference intervals from industrialized countries. Fetal biometric
measurements were obtained monthly from pregnant women enrolled in a longitudinal
ultrasound study in Kinshasa, Democratic Republic of Congo. Women with a singleton
pregnancy and certain gestational dates (ultrasound derived gestational age within 14 days
of LMP estimate) were included in the analysis (n=144). A total of 755 monthly ultrasound
scans were included with an average of four scans per fetus (SD=1). Estimated fetal weight
(EFW) was calculated at each ultrasound using the Hadlock algorithm. A linear mixed effect
model that incorporated random effects for the intercept and slope was fitted to log-
transformed estimated fetal weight as a function of gestational age. Reference intervals (5th,
10th, 50th, 90th and 95th centiles) were then derived from these models. The 50th centile EFW
for this low resource sub-Saharan Africa population were on average, consistently lower than
fetuses born in industrialized populations. Differences observed in the outer centiles were
largely due to variation in study design and statistical techniques. This fetal size nomogram
should improve diagnosis of IUGR in resource poor settings with a high incidence of
maternal malaria infection.
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INTRODUCTION
Ultrasound assessment of intrauterine growth can be used as a clinical tool to identify
abnormally growing fetuses at risk of poor birth outcome and to evaluate fetal response to
maternal interventions. Fetal size nomograms are used to assess the estimated fetal weight
(EFW) of a fetus of known gestational age against a reference standard at a certain point in
gestation. Conventionally, fetal weight estimates below the 10th centile are suggestive of
intrauterine growth restriction (IUGR).150 This definition, however, is highly dependent on the
origin of the reference population and most currently available nomograms were derived
from industrialized, primarily Caucasian, populations. Some studies have demonstrated
racial and ethnic variation in fetal growth patterns151-153 and maternal and environmental
factors are also likely to play a role.154 For example, in low resource sub-Saharan Africa
populations, maternal HIV and malaria infection, chronic under-nutrition, and micronutrient
deficiency are often endemic and are highly associated with lower birth weight.2,15
Although minimal data exist regarding in utero fetal growth patterns in sub-Saharan Africa,
mean birth weights (2,900-3,200 grams) are lower than industrialized countries (3,300-3,500
grams) and rates of SGA are two to three fold higher (15% in sub-Saharan Africa versus 4-
8% in the United States and Europe).15,1 It is likely that in utero growth patterns also vary
between these populations, and fetal weight nomograms created from industrialized
countries may not serve as appropriate benchmarks for identifying growth restricted fetuses
in these underserved populations. If a nomogram identifies an inappropriately large
proportion of fetuses as IUGR, the clinical usefulness of this tool to distinguish fetuses that
are truly growth compromised and would benefit from maternal interventions such as
nutritional supplementation or malaria treatment, is vastly reduced.
The purpose of this study was to develop a fetal size nomogram for use in resource poor
settings with a high prevalence of maternal malaria infection and under-nutrition. The derived
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reference intervals are also compared to commonly used nomograms from industrialized
countries to assess the applicability of such nomograms for low resource populations.
MATERIALS AND METHODS
Study population
The study population consisted of 182 women enrolled in a prospective longitudinal cohort
study conducted between May 2005 and May 2006 at the Binza Maternity Hospital in
Kinshasa, Democratic Republic of Congo. Binza Maternity Hospital is one of the oldest
maternities in Kinshasa and serves a predominately urban low-income population. The
purpose of this study was to understand the effects of maternal malaria and nutritional status
on fetal growth. At baseline, all participants had a singleton pregnancy and no evidence of
high blood pressure (systolic >140 mmHg and/or diastolic >90 mmHg) or ultrasound
detected fetal abnormality. Women were enrolled before 22 weeks gestation and returned to
the maternity hospital for monthly follow-up visits during which malaria status and maternal
anthropometrics were assessed and fetal biometry measured by ultrasound. Delivery
information is available for 98% of enrolled women. All participants provided written informed
consent to participate in the study and the protocol was approved by the Institutional Review
Boards of the University of North Carolina, Chapel Hill and the University of Kinshasa.
We excluded three stillbirths and 35 women with uncertain gestational dates (LMP date
differed from ultrasound derived date by more then ±14 days) leaving 144 fetuses in this
analysis. Women who developed complications during pregnancy or at delivery were not
excluded in order to obtain a representative population. Five newborns with structural
malformations identified at delivery (one cleft palate/eye orbit deformity, one mild nuchal
hump, one club foot/lower limb deformity, and two infants with polydactyly) were also
included.
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Sixty one percent of women had at least one positive malaria smear. Of those, 61% were
positive only once, 30% had two positives and 9% had three or more positive smears. All
enrolled women received two courses of presumptive malaria therapy with sulfadoxine-
pyrimethamine between 16-27 weeks and 28-32 weeks gestation, regardless of malaria
status. In addition, all antenatal positive parasitemias were treated. Five women (3%) were
HIV positive. Maternal anthropometrics, hematocrit and prevalence of positive malaria
parasitemia were similar to other sub-Saharan African populations,153,28,92 however the HIV
prevalence is among the lowest for antenatal populations.155 Tobacco and alcohol use during
pregnancy was minimal.
There were 11 cesarean sections (8%) and 14 women (10%) with delivery complications
(two premature rupture of the membrane, eight breech deliveries and/or prolonged or
obstructed labor, four post-partum hemorrhages). Six infants (4%) were delivered at <37
weeks gestation and there were three early neonatal deaths (2%). Infant anthropometrics
and length of gestation were similar to delivery outcomes in other areas with endemic
malaria.156 The prevalence of low birth weight (<2,500 grams) and preterm delivery were
lower than reported for other populations receiving presumptive malaria treatment.53,157
Overall, this population of mothers and fetuses could be considered an adequate
representation of a typical sub-Saharan African population.
Ultrasound measurements
All ultrasounds were performed using a GE Logiqbook System by a single Congolese
obstetrician-gynecologist. Biparietal diameter (BPD), head circumference (HC), abdominal
circumference (AC), and femur length (FL) were measured using standard techniques.147
Estimated fetal weight in grams was calculated using the Hadlock algorithm27.
All ultrasound images were saved onto CD-ROM as jpeg files. A 10% sample of
ultrasound images was assessed for quality by a maternal-fetal medicine physician at the
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University of North Carolina, Chapel Hill. Ninety-two percent of reviewed images were
deemed adequate for clinical assessment; 7% of questionable quality and 1% of poor quality
(i.e., not all biometry landmarks clearly visible, shadowing in the image or poor tracing of the
length of circumference). Intra-operator variability in measuring fetal biometry was assessed
in ten patients. The correlation between two independent measurements on the same fetus
was r=0.99 for each of BPD, HC, and FL, and r=0.98 for AC.
Statistical analysis
All analyses were performed in SAS, version 9.1 (SAS, Cary, NC). Due to sparse data in
the first trimester and post-term, analyses were limited to 15 and 40 weeks gestation.
Gestational age was calculated in days according to the ultrasound derived dates. The 50th
centile and outer reference centiles (i.e., 5th, 10th, 90th, and 95th) were derived using a linear
mixed effect model approach.125 This method accounts for variability in estimated fetal
weight at both the between-subject and within-subject levels, by incorporating subject-
specific effects for the intercept and growth (slope) component. Briefly, estimated fetal
weight (the dependent variable) was log-transformed to ensure normality and reduce
heteroscedasticity of the dependent variable residuals. The independent (time) variable was
a best fitting second degree fractional polynomial linearizing function of gestational age in
days.134 If ijZ represents the log-transformed estimated fetal weight and ijX represents the
factional polynomial transformation of time, then the mean ( )ijμ and variance
2( )ijσ of ijZ at
transformed time ijX are:
0 1( ) ( )ij ij j j ij ijμ E Z β β T r= = + +
= = + + +
0 1 0 1
2 2 2 2 2
,var( ) ( ) 2 ( )j j j j ijij ij β β ij β β ij rσ Z σ σ X σ X σ
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where
0
2
j
 represents the (between-women) variance of the random
intercepts, 1
2
j represents the (between-women) variance of the random slopes, 0 1,j j  is the
covariance between them and 2error is the estimated within-women variance.
The reference intervals for the untransformed estimated fetal weights, iY are calculated
from the mean and variance above as exp( )ij ijµ ± where ij is the standard error of ijZ and
 is the standard distribution function (±1.96 for the 2.5th and 97.5th centile, ±1.645 for the 5th
and 95th centiles, ±1.282 for the 10th and 90th centiles, and ±0.674 for the 25th and 75th
centiles, and 0 for the 50th centile).
The raw and studentized residual errors were visually inspected by plots of the errors
against gestational age. Normality in the distribution of the errors was determined by visual
inspection of plots and subsequently confirmed using the Shapiro-Wilks test. Influence
diagnostics, based on iteratively deleting each subject from the model, was used to identify
fetuses that over influenced the estimates of the fixed effects and/or precision of the
variance estimates on overall model fit.
We compared our derived reference intervals to those developed from three industrialized
populations (see Table 4.3 for details about each study). For each gestational week, we
calculated the percent difference in estimated fetal weight between the industrialized
reference value and the Congo nomogram as Re Re[( / ) 100]ference Congo ferenceEFW EFW EFW  .
Thus, percent differences greater than zero represent a higher EFW value in the
industrialized reference compared to the value from the Congo nomogram (overestimation)
while percent differences below zero represent lower EFW values in the industrialized
nomogram (underestimation).
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RESULTS
The reference intervals were based on 144 singleton fetuses that underwent 755
ultrasound scans. The average number of scans per fetus was four (SD=1) and the average
duration between scans was 29 days (SD=4 days). Maternal and fetal characteristics of the
study population are provided in Table 4.1. The mean maternal age at enrollment was 27.4
years (SD=5.5) and 29% of women were primigravid. The distribution of ultrasound
examinations and descriptive statistics of the estimated fetal weight variables by gestational
age are provided in Table 4.2. The best fitting fractional polynomial of time ijT was a
quadratic polynomial defined as 24.70794 0.03148 0.0007ij ij ijX T T= +  . The mean and
variance of the mean were estimated with the following fitted regression models:
( ) 0.1195 1.0213( )ij ij ijμ E Z X= =  +
2 2var( ) 0.04519 0.001323( ) 2( 0.00761) 0.003371ij ij ij ijσ Z X X= = + +  +
Figure 4.1 shows the predicted centiles for gestational ages 15 to 40 weeks superimposed
on the raw estimated fetal weight data. Growth is continuously linear through term, with
variance increasing with advancing gestational age. Raw and studentized residuals of
estimated fetal weight were obtained from the mixed model regression equations presented
above and plotted against gestational age (Figure 4.2). The residuals are evenly dispersed
above and below zero at all gestational ages suggesting that the logarithmic transformation
of estimated fetal weight was adequate to meet the assumption of constant variance of the
residual errors.
Comparison to nomograms from industrialized countries
Figure 4.3 shows the percent difference in estimated fetal weight comparing the reference
intervals from Congo to three nomograms of industrialized populations. For the 50th centile,
all 3 nomograms overestimated the 50th centile value for Congolese fetuses by roughly 5% to
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12%, and the difference tended to be highest at earlier gestational ages.
The Hadlock 10th centiles slightly underestimated the Congo 10th centile at early
gestational ages whereas the 90th centile of consistently overestimated fetal weight early in
gestation; both differences became less pronounced near term. Both the 10th and 90th
centiles derived by Gallivan consistently overestimated the corresponding Congo centiles.
The Johnsen nomogram also consistently overestimated the inner and outer centiles,
however for both, the overestimation gradually decreased with advancing gestation.
DISCUSSION
This analysis shows that the 50th centile estimated fetal weights in this low resource sub-
Saharan Africa population are, on average, consistently lower than fetuses born in
industrialized populations. Previous ultrasound studies of fetal biometry conducted in Africa
in the late 1980’s found similar results. In an investigation of 200 cross-sectional ultrasound
measurements, Ayangade and Okonofau110 found that the BPD of Nigerian fetuses were
consistently lower between 20 to 40 weeks when compared to a European standard. These
findings were similar to other studies from Nigeria113 and Zimbabwe.112 A study of AC based
upon a combination of cross-sectional and longitudinal ultrasound scans of 558 women also
found consistently lower mean AC measurements in Nigerian fetuses compared to a
European standard.111
We hypothesize that environmental factors including maternal nutritional deficiencies and
infections such as malaria and HIV, may explain some of the difference in achieved fetal size
in this low resources population. Because a nomogram serves as reference data, it should
relate to normal fetuses and be derived from as unselected a population as possible.118 In
order to be most useful as a clinical tool, the nomogram should adequately represent the
range of maternal characteristics and environmental conditions relevant to the population
being screened. In the context of sub-Saharan Africa, excluding women with poor nutritional
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status or antenatal malaria infections would create an “artificially healthy” source population,
which is likely to produce fetuses with higher in utero weights. This would lead to reference
intervals that are shifted upward and consequently incorrectly over diagnose IUGR. Our
population was comprised of women living in an urban, low income setting with a high
prevalence of malaria and evidence of maternal under-nutrition. This population provides a
reasonable representation of normative environmental conditions for women living in similar
sub-Saharan African communities. However, it should be noted that the prevalence of poor
birth outcomes including LBW and PTD were lower in this population compared to other
countries in the region. These differences are likely related to the lower prevalence of HIV in
this Congo population as well as the high level of antimalarial prophylaxis and treatment
coverage achieved in the parent study.
Inconsistencies in study design and statistical methodologies used in past studies are also
likely to explain some of the observed difference. For example, the choice of algorithm used
to estimate fetal weight could influence the centile values of a nomogram. A recent study that
compared 25 different ultrasonographic algorithms for estimating fetal weight demonstrated
a range of mean absolute error between estimated fetal weight and birth weight from 263 to
646 grams.158 We chose the Hadlock algorithm for this analysis to facilitate comparability to
other nomograms and because composite algorithms that combine several biometric
parameters together provide more accurate weight estimates than those that use fewer
parameters.27,159 The Hadlock algorithm provided a reasonable estimate of fetal weight in
our population, with absolute differences between the predicted 50th centile EFW value and
the post-natal actual birth weight measurement of 3.7%, 7.1%, and 6.9% for 38, 39 and 40
weeks, respectively. We also found the Hadlock algorithm to be fairly robust to
misspecification of gestational dates. A sensitivity analysis of the Hadlock algorithm that
compared the modeled 50th centile fetal weight values obtained from a subset of women with
and without certain gestational dates, demonstrated a difference of only 6 to 20 grams, with
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the greatest difference occurring between 30 and 35 weeks.
Secondly, varying methods used to characterize gestational dates may effect fetal weight
estimation and IUGR diagnosis. For example, utilizing ultrasound derived gestational age, as
opposed to LMP derived age, often shifts the mean gestational age of the population to the
left (earlier) by approximately two weeks, consequently lowering the proportion of fetuses
classified as IUGR and inflating the preterm delivery rate.160,161 We only included women in
our analysis with ultrasound confirmed LMP dates. The definition of gestational age (i.e.,
completed weeks, exact weeks, or days) can also lead to discrepancies in EFW estimation.
Completed week definitions may introduce systematic errors for most biometric parameters
that rapidly increase during gestation. Our nomogram was based on gestational age
classified in days as previously recommended,162 thereby avoiding the “averaging” of fetal
weights within six-day intervals.
In clinical practice, values at the extremes of a nomogram are typically of more interest
and greater importance than mean values. Variation in the lower centile values between
different populations can lead to over- or under diagnosis of IUGR, and highlight the
importance of utilizing nomograms created from a relevant source population with rigorous
statistical techniques. In this analysis, comparisons of outer centile values between the local
population and industrialized population nomograms revealed inconsistent patterns. The
differences observed are likely due in large part to differing statistical approaches used to
create the reference intervals. Early attempts to develop fetal size nomograms from
longitudinal ultrasound studies were based on methods applicable for cross-sectional
data.119,120,121 This approach ignores the high correlation amongst biometric parameters over
time (gestational age) and assumes that the fetal growth velocity, and the estimated model
residual errors, are constant over time. These assumptions are not appropriate for fetal
growth data, which generally demonstrates a pattern of increased variability in estimated
fetal weight with increasing gestational age. Several studies, including the Gallivan study
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used as a comparison here, attempted to improve the statistical methods for analyzing
longitudinal data by fitting a separate regression curve to each fetus and using the average
variation (i.e., average of the individual regression coefficients) among these curves to derive
the size centiles.122,123 This method, however, is also flawed and leads to outer centiles that
are too narrow because it only accounts for between-fetus variation.124 The mixed effect
model approach utilized in our study overcomes the above limitations by considering both
the between- and within-fetus variation in the calculation of the reference intervals. This
method should result in more accurate estimation of reference intervals and better IUGR
diagnosis. The nomogram developed by Johnsen utilized a similar statistical approach and
as expected, provided the most consistent comparison to the local nomogram.
A fetal size nomogram is used to determine if a particular fetus has attained an
appropriate weight at a particular gestational age. This tool can be a helpful diagnostic
addition to obstetric care even in resource poor settings in which it is only possible to scan a
woman one time during pregnancy. For example, the nomogram can be used to identify
fetuses that appear to be faltering in growth and are likely to benefit from maternal
interventions, such as presumptive antimalarial treatment regimens, hypertension
management, bednet programs, and nutritional supplementation. In the context of
intervention research, longitudinal ultrasound studies that scan women before and after
implementation of an intervention can be used to identify time points during pregnancy in
which the intervention has maximum impact.
In summary, this fetal size nomogram was developed from an unselected antenatal
population that adequately represents a typical urban, resource poor sub-Saharan African
population. We utilized advanced statistical techniques that address statistical clustering of
the longitudinal data to produce valid reference intervals. Our findings lend support to the
hypothesis that maternal characteristics including malaria infection and under-nutrition likely
lead to lower fetal weight when compared to 50th centile values from industrialized
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populations. This customized nomogram should improve the diagnosis of IUGR in resource
poor populations.
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Figure 4.1. Estimated fetal weight centiles by gestational age with raw fetal weight
values superimposed on the plot, Kinshasa, Democratic Republic of Congo, 2005-
2006
(Dotted line=5th and 95th centiles, Solid thin line=10th and 90th centiles, Solid thick line=50th centile)
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Figure 4.2. Studentized residuals across gestational age from the fit of the regression
model
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Figure 4.3. Percent difference comparing 10th, 50th and 90th centiles
(Dotted line=Hadlock; Solid thin line=Gallivan; Solid thick line=Johnsen)
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Table 4.1. Maternal and fetal characteristics of the study population (N=144),
Kinshasa, Democratic Republic of Congo, 2005-2006
Mean/Percent SD
Maternal characteristics
Age at enrollment (years) 27.4 5.5
BMI at enrollment (kg/m2) 23.7 3.7
Height (cm) 161.4 7.4
MUAC at enrollment 26.5 3.2
Weight gain per month (kg) 1.6 1.5
Hematocrit at enrollment (%) 33.7 3.8
Primigravid 29% --
Malaria parasitemia at enrollment 30% --
HIV positive 3% --
Infant characteristics
Birth weight (g)* 3041 413
Birth length (cm)† 49.7 1.9
Birth head circumference (cm) † 34.1 2.4
Gestational age at birth (days)* 275 11
Low birth weight (<2,500 grams) 6% --
Preterm delivery (<37 weeks) 4% --
Female gender 56% --
* Data available for 142 infants
† Data available for 137 infants
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Table 4.2. Distribution of ultrasound examinations by gestational week and
descriptive statistics of the estimated fetal weight variable by gestational age,
Kinshasa, Democratic Republic of Congo, 2005-2006
Estimated fetal weight (grams)Gestationalage
(weeks)
#
observations Mean SD Minimum Maximum CV
15 2 128 7.9 122 134 6.2
16 13 140 11.6 124 155 8.3
17 11 166 12.5 152 187 7.5
18 18 217 18.7 176 251 8.6
19 25 271 19.3 231 295 7.1
20 29 319 20.2 271 353 6.3
21 35 382 36.5 320 470 9.5
22 49 464 37.7 390 560 8.1
23 22 535 38.7 472 643 7.2
24 30 617 52.3 520 742 8.5
25 40 745 69.1 625 907 9.3
26 38 874 80.1 700 1062 9.2
27 32 988 85.0 856 1198 8.6
28 36 1119 101.8 944 1341 9.1
29 33 1314 125.2 1076 1528 9.5
30 40 1480 126.2 1275 1761 8.5
31 29 1661 210.5 1351 2466 12.7
32 36 1813 181.3 1402 2203 10.0
33 40 2073 239.7 1615 2524 11.6
34 32 2226 233.9 1814 2929 10.5
35 30 2536 259.3 2034 3245 10.2
36 38 2666 308.3 1639 3227 11.6
37 34 2935 293.4 2301 3622 10.0
38 34 3152 324.4 2466 3975 10.3
39 21 3360 357.3 2875 4529 10.6
40 8 3296 254.9 2875 3549 7.7
Total 755
SD=Standard deviation
CV=Coefficient of variation (SD/mean), expressed as percent
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Table 4.3. In utero fetal weight centiles by week of gestation Kinshasa, Democratic
Republic of Congo, 2005-2006
Gestational
age
(weeks)
2.5th 5th 10th 25th 50th 75th 90th 95th 97.5th
15 96 99 102 106 112 118 124 128 131
16 121 124 127 133 140 147 154 158 162
17 150 154 158 165 173 182 190 195 200
18 186 190 195 203 213 223 233 239 245
19 227 232 238 248 260 273 284 292 298
20 275 281 289 301 315 330 345 353 361
21 331 339 347 362 380 398 415 426 435
22 395 404 415 433 454 476 497 509 521
23 468 479 491 513 539 565 591 606 620
24 550 563 578 604 635 667 698 717 733
25 641 656 675 706 743 782 819 842 862
26 742 760 782 820 864 911 955 982 1007
27 852 874 900 945 997 1053 1106 1138 1167
28 971 997 1028 1081 1143 1209 1271 1310 1345
29 1100 1130 1166 1228 1301 1378 1452 1498 1539
30 1237 1272 1313 1386 1471 1561 1647 1700 1748
31 1381 1421 1469 1552 1651 1755 1854 1917 1972
32 1532 1578 1632 1727 1840 1959 2074 2145 2209
33 1687 1739 1801 1909 2036 2172 2302 2384 2457
34 1846 1904 1973 2094 2238 2391 2538 2630 2713
35 2006 2070 2147 2282 2442 2613 2778 2881 2974
36 2165 2236 2321 2470 2647 2836 3019 3133 3236
37 2321 2398 2491 2655 2848 3056 3257 3383 3496
38 2471 2556 2656 2833 3044 3270 3488 3626 3749
39 2614 2705 2813 3004 3230 3474 3709 3858 3991
40 2747 2844 2959 3162 3404 3664 3916 4075 4218
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Table 4.4. Comparison of estimated fetal weight reference intervals comparing Kinshasa, Democratic Republic of
Congo and industrialized population nomograms
Present study Hadlock129 Gallivan123 Johnsen163
Population Dem Rep. ofCongo, African
United States,
Caucasian
United Kingdom,
Caucasian
Norway, 98% of
European origin
Study design Longitudinal Cross-sectional Longitudinal Longitudinal
N (women) 144 392 67 635
N (scans) 755 392 434 1795
Avg. scan/women 5 1 6 3
EFW formula Hadlock27 Hadlock27 Hadlock27 Combs164
GA weeks 10th 50th 90th 10th 50th 90th 10th 50th 90th 10th 50th 90th
20 289 315 345 275 331 387 289 344 410 283 340 408
25 675 743 819 652 785 918 709 816 940 717 835 972
30 1313 1471 1647 1294 1559 1824 1421 1614 1834 1403 1619 1868
35 2147 2442 2778 2154 2595 3036 2362 2663 3003 2242 2593 2998
40 2959 3404 3916 3004 3619 4234 3240 3633 4074 3021 3511 4081
CHAPTER 5:
SENSITIVITY ANALYSIS OF MALARIA AND UNDER-NUTRITION ANALYSIS
UTILIZING THE CONGO FETAL SIZE NOMOGRAM AS THE REFERENCE
FOR IUGR DIAGNOSIS
PURPOSE
We conducted a sensitivity analysis to assess the robustness of the associations between
IUGR, malaria and under-nutrition (Chapter 3) using the Congo fetal size nomogram as the
standard for defining IUGR.
MATERIALS AND METHODS
A total of 757 observations after 22 weeks gestation were used in this sensitivity analysis
(one fetus with an ultrasound at 42 weeks gestation was not included as the Congo derived
nomogram covers only 15-40 weeks). We began by assigning an IUGR diagnosis to each
observation utilizing the 10th centile of the Congo nomogram values (Table 5.1). Next, we
compared the distribution and characteristics of the IUGR cases diagnosed using the
Hadlock129 and Congo nomograms and re-fitted the log-binomial models to determine if the
resultant Risk ratios (RR) and 95% confidence intervals (CI) differed by IUGR definition
(Tables 5.2-5.7).
RESULTS
The Congo 10th centile is higher than the Hadlock tenth centile on average by 20 grams
early in gestation and then drops below the Hadlock values from weeks 35 to 40 (Table 5.1).
More fetuses were categorized as IUGR using the Congo nomogram (n=107) as compared
to the Hadlock nomogram (N=75). The gestational age distribution of IUGR cases is shown
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in Figure 5.1. As expected based on the gestational age specific pattern of the absolute and
percent differences, the Congo nomogram characterized more fetuses as IUGR until week
30, after which the two nomograms performed equally.
The concordance in IUGR diagnosis between the Hadlock nomogram and the Congo
nomogram was 95.5%. The Kappa statistic is often used to compare the actual agreement in
how two algorithms (or observers) classify a particular outcome, against the agreement
which might be expected by chance. This index ranges of from positive one (perfect
agreement) to negative one (complete disagreement), with zero indicating no agreement
above that expected by chance. Kappa can be thought of as the chance-corrected
proportional agreement. The Kappa value was 0.789 with a 95% confidence interval of
(0.721, 0.857). A kappa in this range is considered to have a substantial level of agreement.
No appreciable differences were observed among the associations between IUGR and
maternal sociodemographic factors, fetal gender or anemia (Table 5.3). The RR for
antimalarial treatment was slightly attenuated and no longer statistically significant using the
Congo IUGR definition. Results for the independent associations of incident and cumulative
malaria remained largely unchanged (Table 5.4). The risk ratio and 95% CI for the
continuously coded cumulative malaria variable were slightly higher for one and two malaria
infections utilizing the Congo nomogram, and the trend test P-values became lower and
highly significant (0.02) for the model that adjusted for both age and maternal weight gain.
Risk ratios for the binary 3 positives (vs. <3 positives) malaria definition were slightly
attenuated using the Congo IUGR model, however conclusion regarding statistical
significance remained the same.
Among the various maternal anthropometric indicators, results for the MUAC change and
weight gain indicators were the most divergent. When utilizing the Hadlock IUGR definition,
both MUAC change and weight gain suggested a stronger effect among women with low
baseline BMI, although these differences were not statistically significant. In contrast, when
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using the Congo IUGR definition, the effect of both variables on IUGR risk was essentially
null at either level of baseline BMI (Table 5.5). Similarly, the statistically significant strong
second trimester effect demonstrated in the original analysis was also attenuated when the
Congo definition was used (Table 5.6).
The strong effect measure modification patterns identified using the Hadlock IUGR
definition largely held when the data were re-analyzed (Table 5.7). Although the RRs are
slightly attenuated, conclusions regarding the statistical significance of the effect measure
modification were essentially the same. The only exception was the MUAC change indicator,
which was no longer a significant effect measure modifier in the cumulative malaria analysis.
As well, the overall precision of the estimates improved when utilizing the Congo definition.
DISCUSSION
In general, the results of the malaria analysis appear very robust to changes in the
definition of IUGR. The RRs and conclusions regarding statistical significance were nearly
identical in all analyses with malaria as the main exposure variable. The maternal
anthropometric exposures were more sensitive to changes in the IUGR definition, with the
MUAC change and maternal weight gain variables showing the most contradictory results.
The loss of effect for these two variables likely has to do with the differing gestational age
distribution of the IUGR cases using the two definitions. The Congo nomogram characterized
a much higher proportion of fetuses as IUGR in the second trimester and as a result, the
strong trimester effects of MUAC and weight gain essentially disappeared. The loss of a
strong second trimester effect may explain, at least in part, the attenuation in the RRs for the
independent and modifying effects of these two variables over the whole pregnancy.
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Figure 5.1. Distribution of IUGR cases by gestational age using the Congo and
Hadlock nomograms to define IUGR
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Table 5.1. Comparison of the 10th centile values of the Hadlock nomogram and the
Congo nomogram, 22 – 40 weeks gestation
Gestational age
(weeks)
Congo
10th centile
Hadlock
10th centile
Absolute
difference
Percent
difference
22 415 398 17 4
23 491 471 20 4
24 578 556 22 4
25 675 652 23 3
26 782 758 24 3
27 900 876 24 3
28 1028 1004 24 2
29 1166 1145 21 2
30 1313 1294 19 1
31 1469 1453 16 1
32 1632 1621 11 1
33 1801 1794 7 0
34 1973 1973 0 0
35 2147 2154 -7 0
36 2321 2335 -14 -1 
37 2491 2513 -22 -1 
38 2656 2686 -30 -1 
39 2813 2851 -38 -1 
40 2959 3004 -45 -2 
Absolute difference = Congo 10th centile – Hadlock 10th centile
Percent difference = (Congo 10th centile – Hadlock 10th centile) / Congo 10th centile) * 100
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Table 5.2. Concordance between the Congo and Hadlock nomograms
Hadlock
nomogram
Congo
nomogram
IUGR Not IUGR
IUGR 74 33 107
Not IUGR 1 649 650
75 682 757
Percent concordant = (74 + 649) / 757 = 95.5%
Kappa statistic = 0.789 (95% confidence interval: 0.721, 0.857)
93
Table 5.3. Baseline and visit-specific characteristics of pregnant women
and risk ratios (RR) and 95% confidence intervals (CI) for IUGR using Congo
nomogram
RR† 95% CI
Maternal age (years)
18-24 1.3 0.7, 2.4
25-29 1.0 Ref
30 1.2 0.6, 2.2
Socioeconomic status
High 1.0 0.5, 2.0
Low 1.0 Ref
Gravida
1-2 1.3 0.8, 2.1
3 1.0 Ref
Fetal gender
Male 0.7 0.4, 1.2
Female 1.0 Ref
Treated in previous month
Yes 0.8 0.6, 1.0
No 1.0 Ref
Hematocrit at visit
<30 0.6 0.2, 1.5
30 1.0 Ref
† Unadjusted. Model included 757 study visits and 107 episodes of IUGR.
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Table 5.4. Risk ratios (RR) and 95% confidence intervals (CI) for the association between IUGR and
incident and cumulative malaria infection using Congo nomogram
RR† 95% CI RR‡ 95% CI RR§ 95% CI
Malaria parasitemia at
visit
Positive 1.2 0.8, 2.0 1.2 0.8, 2.0 1.4 0.8, 2.4
Negative 1.0 Ref 1.0 Ref 1.0 Ref
Cumulative malaria
parasitemia up to visit
0 1.0 Ref 1.0 Ref 1.0 Ref
1 1.0 0.6, 1.7 1.0 0.6, 1.7 1.1 0.6, 1.7
2 1.4 0.7, 2.6 1.4 0.8, 2.6 1.6 0.9, 3.0
3 2.1 0.7, 6.5 2.1 0.7, 6.5 3.6 1.5, 8.4
PTrend = 0.17 PTrend = 0.19 PTrend = 0.02
Cumulative malaria
parasitemia up to visit
2 positive
<2 positive
1.5
1.0
0.9, 2.7
Ref
1.5
1.0
0.9, 2.7
Ref
1.9
1.0
1.1, 3.2
Ref
3 positive
<3 positive
1.9
1.0
0.6, 6.2
Ref
1.9
1.0
0.6, 6.2
Ref
3.2
1.0
1.4, 7.4
Ref
† Unadjusted. Model included 757 study visits and 107 episodes of IUGR.
‡ Adjusted for age. Model included 757 study visits and 107 episodes of IUGR.
§ Adjusted for age and weight gain. Model included 587 visits with complete data for weight gain and 92 episodes of IUGR.
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Table 5.5. Risk ratios (RR) and 95% confidence intervals (CI) for the association between IUGR
and maternal anthropometric indicators using Congo nomogram
RR† 95% CI RR‡ 95% CI RR§ 95% CI
Time-independent variables
Baseline BMI
<19.8 kg/m2
19.8 kg/m2
1.3
1.0
0.7 2.3
Ref
1.2
1.0
0.7, 2.2
Ref
1.0
1.0
0.5, 2.0
Ref
Short stature
<150 cm
150 cm
1.3
1.0
0.5, 3.5
Ref
1.3
1.0
0.5, 3.4
Ref
1.2
1.0
0.3, 4.1
Ref
Time-dependent variables
MUAC change per month #
Baseline BMI <19.8 kg/m2
Baseline BMI 19.8 kg/m2
0.8
1.1
0.3, 2.2
0.8, 1.6
0.8
1.1
0.3, 2.2
0.8, 1.6
0.8
1.0
0.2, 4.5
0.7, 1.4
Maternal weight gain per month**
Baseline BMI <19.8 kg/m2
Baseline BMI 19.8 kg/m2
--
--
--
--
--
--
--
--
1.3
1.3
0.5, 3.6
1.0, 1.9
† Unadjusted. Model included 757 study visits and 107 episodes of IUGR.
‡ Adjusted for age. Model included 757 study visits and 107 episodes of IUGR.
§ Adjusted for age. Model included 587 visits with complete data for weight gain and 92 episodes of IUGR.
# Comparing MUAC change in the previous month of <0 cm vs.  0cm.
** Comparing maternal weight gain in the previous month of <1.5 kg per month vs. 1.5 kg per month.
96
Table 5.6. Trimester specific risk ratios (RR) and 95% confidence intervals (CI) for the association
between IUGR and change in MUAC and weight gain using Congo nomogram
IUGR in second
trimester
IUGR in third
trimester
RR 95% CI RR 95% CI
MUAC change*
Over entire 2nd trimester 1.1 0.6, 1.9 -- --
Over entire 3rd trimester -- -- 1.1 0.6, 2.0
Weight gain per month†
Second trimester 1.4 0.7, 2.8 -- --
Third trimester -- -- 1.3 0.8, 1.9
* Unadjusted. Models included 217 study visits and 36 episodes of IUGR in the second trimester and 525 study visits
and 71 episodes of IUGR in the third trimester. Comparing MUAC change over the whole trimester of <0 cm vs. 0 cm.
† Unadjusted. Models included 160 study visits and 29 episodes of IUGR in the second trimester and 427 study visits
and 63 episodes of IUGR in the third trimester. Comparing maternal weight gain in the previous month of <1.5 kg per month
vs. 1.5 kg.
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Table 5.7. Risk ratios (RR) and 95% confidence intervals (CI) for the association between IUGR and
malaria, stratified by maternal anthropometrics using Congo nomogram
RR* 95% CI RR† 95% CI RR‡ 95% CI
Malaria parasitemia at visit
(Positive vs. negative)
Baseline BMI <19.8 kg/m2
Baseline BMI 19.8 kg/m2
3.3
0.9
1.8, 5.7
0.5, 1.7
3.2
0.9
1.8, 5.7
0.5, 1.7
5.0
0.9
2.6, 9.6
0.5, 1.8
Height <150 cm
Height  150 cm
3.9
1.2
1.4, 10.9
0.7, 1.9
3.7
1.2
1.2, 10.8
0.7, 1.9
3.9
1.2
0.9, 16.2
0.7, 2.2
MUAC gain <0 cm in past month
MUAC gain 0 cm in past month
2.0
0.8
1.1, 3.8
0.3,1.9
2.0
0.8
1.1, 3.8
0.3,2.0
2.2
0.7
1.2, 3.8
0.3,1.8
Weight gain <1.5 kg in past month
Weight gain 1.5 kg in past month
--
--
--
--
--
--
--
--
1.4
1.4
0.7, 2.8
0.7, 2.7
Cumulative malaria parasitemia
( 2 positive vs. < 2 positive)
Baseline BMI <19.8 kg/m2
Baseline BMI 19.8 kg/m2
3.3
1.3
1.6, 6.4
0.7, 2.6
3.2
1.3
1.6, 6.4
0.7, 2.5
5.0
1.6
2.8, 8.7
0.8, 2.9
Height <150 cm
Height 150 cm
3.3
1.4
0.5, 20.4
0.8, 2.6
3.6
1.4
0.7,18.9
0.7, 2.6
2.3
1.9
0.3,16.5
1.1, 3.2
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Table 5.7., continued
RR* 95% CI RR† 95% CI RR‡ 95% CI
MUAC gain <0 cm in past month
MUAC gain 0 cm in past month
1.4
1.5
0.6, 3.1
0.9, 2.7
1.4
1.5
0.6, 3.2
0.8, 2.7
2.2
1.7
1.0, 4.5
1.0, 2.9
Weight gain <1.5 kg in past month
Weight gain 1.5 kg in past month
--
--
--
--
--
--
--
--
1.7
2.1
0.9, 3.3
1.1, 3.8
* Unadjusted. Model included 757 study visits and 107 episodes of IUGR.
† Adjusted for age. Model included 757 study visits and 107 episodes of IUGR.
‡ Adjusted for age. Model included 587 visits with complete data for weight gain and 92 episodes of IUGR.
Note: RR pairs highlighted in bold indicate a significant P-value for the interaction term between malaria and the anthropometric
indicator (P-value <0.15).
CHAPTER 6: 
DISCUSSION
Summary of findings
This dissertation provides one of the first longitudinal studies of antenatal malaria
infection. It provides a unique contribution to the pregnancy malaria literature because we
utilized ultrasound to study in utero fetal growth, rather than relying on SGA as a proxy
measure of antenatal growth.
The first analysis focused on two component causes of IUGR, which have heightened
relevance in low resource settings, maternal malaria infection and under-nutrition. In the
case of P. falciparum infection, a causal link to IUGR is primarily mediated though processes
which affect placental function and nutrient transport.42 Whereas under-nutrition and low
energy intake work through metabolic pathways that affect a women’s ability to support the
increasing nutrient demands of the developing fetus, including insufficient plasma volume
expansion, reduction in glucose plasma levels and inadequate deposition of subcutaneous
fat stores.67
In the first analysis, we found that 60% of women had at least one antenatal malaria
infection and we identified IUGR in nearly one third of the fetuses studied (Chapter 3).
Malaria infection was only modestly associated with an increased risk of IUGR in this
population. A single incident malaria infection was not significantly associated with IUGR in
unadjusted or adjusted analyses. The data suggest a trend effect associated with cumulative
malaria exposure. When compared to fetuses with no antenatal malaria exposure, there was
no increased risk of IUGR after just one positive smear (RR=0.9, 95% CI: 0.5 1.6, a slight
increase in risk after two positives (RR=1.2, 95% CI: 0.5, 2.5) and a two fold increase in risk
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among fetuses who were exposed  3 times in utero (RR=2.3, 95% CI: 0.8, 6.3). Data from a
secondary analysis to investigate the effects of malaria infection on mean fetal weight
(Appendix C) support the IUGR findings, with significantly lower attained fetal weight in only
those fetuses exposed  3 times.
We demonstrated that the effect of malaria on IUGR was significantly modified by
maternal nutritional status, such that the highest associations between malaria and IUGR
were among women with poor nutritional status. This pattern was observed in all four of the
anthropometric indicators studied; however, the weight gain indicator did not reach statistical
significance. Repercussions of childhood malnutrition and malaria infection, such as stunting
and low young adult BMI place reproductive age women at increased risk of poor birth
outcome.31-33,165 In women who have become pregnant, the joint effects of these conditions
may act on similar physiologic pathways to reduce uteroplacental blood flow. Further, these
conditions both contribute to maternal anemia, which independently contributes to LBW
through decreased maternal-fetal oxygen transfer.34,35
Analogous findings of a modifying effect of maternal nutritional status have been
demonstrated in other studies of IUGR risk factors. For example, Cliver and colleagues
showed a differential effect of psychosocial profile during pregnancy over different BMI
levels.166 Among women with a poor psychosocial profile during pregnancy, those with low
BMI were at higher risk of IUGR compared to women of normal BMI. Conversely, findings
from LBW prevention trials of aspirin167 and zinc supplementation168 showed the any benefit
of the intervention is largely present only in women with a healthy pre-pregnancy BMI.
In regard to the independent effects of maternal nutritional status, we found that maternal
weight gain was more strongly associated with an increased risk of IUGR in women with low
baseline BMI. A similar association has been demonstrated in studies of LBW and
SGA,76,90,97,102 with risk generally decreasing with increasing BMI values. We demonstrated
that failure to gain weight or accrue arm fat during the second trimester was associated with
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lower fetal weight. Because the fetus grows most rapidly in the third trimester, we might have
expected that third trimester maternal weight or MUAC gain would have a greater impact.
However, many studies have shown that second trimester weight gain93,96,98,99-101 and MUAC
gain73,99,105 are more important. These findings suggest that maternal physiologic changes
that occur earlier in pregnancy, such as increased plasma volume and maternal fat
deposition, may have the greatest impact on fetal growth.
The second analysis consisted of an application of the mixed effects model technique to
develop a fetal size nomogram appropriate for use in low resources settings with a high
prevalence of malaria infection (Chapter 4). Linear mixed effect models appropriately handle
highly correlated longitudinal data by modeling both between- and within-women variation in
the outcome (in this case EFW). The model consisted of a log-transformation of EFW and a
fractional polynomial of gestational age; random effects for both the intercept and slope were
included. Reference intervals (5th, 10th, 50th, 90th and 95th centiles) were derived from the
model and compared to centiles derived from industrialized populations.
We demonstrated that the 50th centile for fetuses in Congo were, on average, consistently
lower than fetuses born in industrialized populations. In contrast, the outer centiles showed
considerable variation, with some reference standards over-estimating the Congo centile
values while others under-estimated them. We believe these differences were largely
determined by variation in study design and statistical techniques used to derive the centiles.
A nomogram developed using a similar mixed effect model approach showed the most
similar pattern to our data.163
Public health implications
Our findings are at variance with previously published sub-Saharan Africa studies, that
found significant associations between malaria and SGA or LBW.28,140,141,142,143,169 In our
study, malaria was only associated with IUGR after repeated infections ( 3) and among
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women with evidence of under-nutrition. These null findings were robust to the use of
different fetal size nomograms to define IUGR (Chapter 5) as well as varying definitions of
gestational age. A central dissimilarity between our study and those previously conducted is
that our protocol called for presumptive treatment, routine malaria screening and prompt
treatment of all positive cases. We hypothesize that rapid case detection and prompt
treatment may have eliminated parasites before they had adequate time to sequester in the
placenta and damage the placental vasculature. This is supported by our findings that
treatment was independently protective against both malaria (data not shown) and IUGR
(Chapter 3), and resulted in higher attained fetal weight (Appendix C).
There have only been two previous studies that have had similar frequent monitoring and
treatment of antenatal parasitemia, both of which were conducted in areas of low malaria
transmission. In these populations, we do see similar null effects for SGA or LBW (note
IUGR measurements are not available as ultrasound was not utilized). For example, a study
from the Thai-Burmese border found no increased risk of SGA associated with antenatal P.
falciparum infection (10.1% SGA prevalence among infected women vs. 10.7% among
uninfected women).148 In the highland areas of Ethiopia where over 80% of placental
infections were due to P. falciparum, there was no increased risk of LBW associated with
placental blood parasitemia at delivery (RR=1.0, 95%CI: 0.2-6.9).149 Thus, our study is the
first to show that even in areas of high P. falciparum malaria transmission, prompt
identification and treatment of sub-clinical malaria infections may prevent fetal growth
restriction from occurring.
The findings from this dissertation have important implications for malaria control policies
in antenatal populations in sub-Saharan Africa. In areas of high malaria transmission, WHO
recommends a three pronged approach to prevention of malaria in pregnancy: (i) use of
insecticide treated bednets, (ii) intermittent presumptive therapy, and (iii) case management
of confirmed positives.170
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In regard to the insecticide treated bednet recommendation, our study did not directly
measure the impact of bednet utilization on malaria infection or IUGR, however all of the
women in our study were provided a free bednet and self reported use of the nets was high
during pregnancy (data not shown). Thus, the findings of our study should be interpreted
within the context of high bed net utilization.
All women in our study received two doses of presumptive treatment with SP. Our findings
add to the body of literature about the beneficial effects of intermittent presumptive treatment
and underscore the importance of scaling up this important intervention. Providing two
courses of presumptive treatment with an inexpensive antimalarial to all pregnant women is
a safe, cost effective intervention171,172 that has been shown to significantly reduce the
prevalence of antenatal peripheral malaria,53,173 placental malaria,53,173-175 malaria associated
anemia,175,176 and birth weight53,173-175,177 in both HIV positive and negative women. Despite
the proven efficacy of this intervention, coverage in sub-Saharan Africa remains below 50%
in many areas, with use generally lower in rural areas.178
Our data also lend support to the WHO recommendations regarding therapeutic
management of positive cases and suggest that routine malaria screening and treatment be
extended to all women, not just women with clinical signs of malaria. In many areas of sub-
Saharan Africa, scarce resources need to be balanced with benefits to patients. We
recognize that it in many resource poor settings, lack of laboratory infrastructure,
microscopists, and high patient volume may make it impractical to routinely screen pregnant
women at every antenatal care visit. At a minimum, however, routine screening and prompt
treatment should be targeted to women at greatest risk of malaria associated poor birth
outcome, including primi- and secundigravida and women with evidence of under-nutrition.
Further, roll out of rapid malaria tests, which have proven to be cost effective and
substantially decrease inappropriate treatment, may also improve our ability to implement
routine screening.179
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To date, most presumptive treatment programs have utilized SP as the drug of choice.
This drug is highly cost-effective at an average cost of about $1-$2 per pregnancy including
service overhead.178 However, the efficacy of SP is starting to wane, as drug resistance
develops throughout sub-Saharan Africa.180 Long term success of this prevention strategy
thus requires the continuous availability of new proven regimens, including artemesinin-
based combination therapies, for presumptive treatment. This has significant economic
implications, however, as these drugs can cost up to ten times more than SP. Thus, it is
important that we conduct research to maximize the efficacy of these new drug regimens by
identifying intervals during pregnancy when the drugs provide the most benefit. For example,
does presumptive treatment early in pregnancy provide the same benefit as waiting until later
in pregnancy? When is the latest possible time during pregnancy that you can give a drug
and still see some fetal benefit? What is the minimum number of presumptive doses that still
offers adequate protection?
The fetal size nomogram we developed is a helpful research tool for this purpose.
Prospective studies that routinely monitor fetuses with ultrasound can be used to identify
intervals during pregnancy when exposures are most harmful and treatments have the
greatest impact. By studying growth achievement before and after an intervention has been
implemented, we can identify when during pregnancy the treatment seems to provide the
greatest benefit. Similar research uses can be extended to other interventions as well,
including therapeutic treatment of clinical malaria, treatment of other infections such as
syphilis, and provision of nutrition supplementation.
Another advantage of using ultrasound and fetal size nomograms in longitudinal studies
such as these is improved efficiency in study design. First, ultrasound can provide more
accurate estimation of gestational age that improves classification of study endpoints. As
well, the use of IUGR endpoints measured during the antenatal period provides direct
assessment of fetal growth and provides more timely results than waiting for birth to measure
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surrogate growth markers such as LBW or SGA.
At present, research purposes such as those discussed above are probably the most
practical uses of fetal size nomograms in low resources settings. In industrialized countries,
these nomograms are often utilized to identify fetuses in distress and who may be
candidates for early induction of labor. Clinical applications such as this are limited in low
resources settings, however, due to a lack of neonatal intensive care facilities to care for
premature infants or infants with under-developed lung capacity.
When utilizing nomograms in any population, certain considerations should be noted.
First, an accurate estimate of gestational age is an essential component of correctly utilizing
a nomogram. In low resource settings, estimates of gestational age are most often
determined through either LMP or post-delivery physical and neurological evaluations such
as the Dubowitz method. Last menstrual period dating can lead to inaccurate results due to
variation in length of menstrual cycles and irregular menses.181 This method is also subject
to recall bias, which may be even more prominent in the African setting where women do not
typically seek antenatal care until early in the second trimester.161,182 Secondly, not all fetuses
categorized as “small” based on the nomogram are necessarily at increased risk of neonatal
morbidity and mortality. This is because not all fetuses that are at or below the 10th
percentile are pathologically growth restricted (i.e., some are constitutionally small), and not
all fetuses that have not met their genetic growth potential are in less than the 10th percentile
for weight. Utilizing a nomogram that has been developed from a relevant reference
population can help to minimize some of the misclassification of this outcome.
Future research directions
The longitudinal study utilized for the aims of this dissertation is a rich source of research
data that can be used to address other clinically important questions related to malaria and
risk factors for IUGR and poor birth outcome in low resource settings. A summary of those
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questions is included below.
The association between malaria and birth outcomes: This dissertation focused on in
utero measurement of fetal growth. An analysis investigating the association between
antenatal and placental malaria on birth outcomes including mean birth weight, LBW and
PTD would provide a nice companion analysis. If the birth outcome analyses also found no
or minimal association with malaria, this would further support the null results we identified
for IUGR.
The association between antenatal and placental malaria infection: This dissertation
focused upon antenatal malaria infections; however, data on placental infection was also
collected. Analyses on the associations between antenatal and placental malaria infection
would be an important contribution to the literature. Many studies of pregnancy malaria are
conducted only at the time of delivery. In these studies, placental histology is often used to
suggest potential timing of infection during pregnancy, for example if the placenta was
chronically infected or just subjected to an insult near the time of delivery. Few studies exist,
however, in which the accuracy of placental malaria to predict “true” antenatal malaria can be
assessed. A study in Thailand which compared the sensitivity of pathology to repeat
measures of parasitemia during pregnancy found that pathology alone my miss up to one-
quarter of antenatal infections.148 They showed that pathology was more reflective of
infections that occurred close to the time of delivery. Our longitudinal study design with
frequent measurement of malaria provides an ideal study design to assess the accuracy of
histology in predicting presence and timing of antenatal infection.
Placental malaria and uteroplacental blood flow: Doppler ultrasound data were also
collected at each ultrasound examination. Evaluating the shape of the flow velocity waveform
of pulsed-wave Doppler ultrasound of the umbilical and uterine artery allows a non-invasive
method for studying placental transformation and fetal hemodynamics. Analysis of Doppler
data would allow us to determine if and when malaria increases the risk of abnormal uterine
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and umbilical artery blood flow and also study whether placental histopathological changes
are associated with increases in uterine or umbilical artery resistance. We could also assess
the relationship between uterine artery blood flow, umbilical artery blood flow, and IUGR.
The association between malaria and asymmetric vs. symmetric growth restriction:
Assessing ratios of individual biometric values can be helpful in identifying a fetus that is
growing asymmetrically. Measures of proportionality can be interpreted as evidence of the
aspects of growth that are compromised by prenatal insults. Menendez et al reported chronic
placental malaria to be associated with a decrease in both length and head circumference,
suggesting a chronic insult.141 By combining accurate timing of gestation (by early
ultrasound), IUGR measurement (by serial ultrasound) and malaria exposure data (by repeat
microscopy), we can ascertain the pattern of malaria infections that are associated with
asymmetric vs. symmetric IUGR.
Nomograms for fetal growth determination: The ultrasound biometry data can be utilized to
develop other types of fetal nomograms for obstetrical use in resource poor settings. For
example, because the ultrasound data was collected longitudinally, it is perfectly suited for
the development for conditional fetal growth nomograms, which can be utilized to track fetal
growth progress over time.
Improving IUGR diagnosis: The sensitivity of IUGR diagnosis can often be enhanced
using other criteria that were collected as part of this study, including amniotic fluid volume
(oliogohydriaminos), fundal height, and abnormal Doppler ultrasound of the umbilical artery.4
It would be interesting to assess how accurately these factors predict IUGR, either
individually or in combination with other factors.
In conclusion, this dissertation addressed clinically important questions concerning the
pathogenesis of malaria infection and under-nutrition on in utero fetal growth and aimed to
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improve the identification of IUGR in resource poor settings. Utilizing longitudinal data
analysis techniques, we sought to determine the association between malaria infection,
maternal under-nutrition and IUGR. We concluded that frequent antenatal monitoring and
prompt treatment of malaria might prevent IUGR, especially in women with evidence of
under-nutrition.
Secondly, we developed a fetal size nomogram for use in resource poor settings and
compared this nomogram with reference intervals derived from industrialized countries. We
found that the 50th centile EFW for Congo fetuses was consistently lower than fetuses born
in industrialized populations; there was large variation in the outer centiles, owing primarily to
differing statistical techniques. We feel that this fetal size nomogram should improve
diagnosis of IUGR in resource poor settings with endemic malaria.
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APPENDIX A:
BASIC SURVIVAL ANALYSIS OF IUGR AND MALARIA
In our study, the prevalence of malaria was highest during the baseline visit and declined
over gestation due in part to provision of presumptive treatment and active case
management of all positive malaria smears. The IUGR outcome was, conversely, less
prevalent early in pregnancy and increased until near term. Before making assumptions
about the overall risk of IUGR associated with malaria over the whole pregnancy, we felt it
was important to ensure that the relationship between these two variables did not change
appreciable over time. To investigate this, we utilized a proportional hazards modeling
process.
To compare survival curves between the malaria exposed and unexposed groups, we
produced a Kaplan-Meier curve and tested for homogeneity in the survival curves using the
log-rank chi-square and the Wilcoxon test. The Kaplan-Meier curve showed the survival was
nearly identical between the two groups until week 34, after which the survival function for
the malaria group decreased slightly faster than the non-malaria group (Figure A.1). Despite
these difference, P-values for the log-rank (p = 0.13) and Wilcoxon tests (p=0.37) were not
statically significant, suggesting that the survival curves were not different from each other
over time.
We tested the proportional hazards assumption to assess if the hazard ratio was constant
over time using two techniques: 1) plots of log-log survival, and 2) test for interaction
between malaria and categorical time. In the plots, parallelism in the log hazards suggests
that the proportional hazards assumption was satisfied; lines that cross one another violate
the proportional hazards assumption. From the log-negative log plots, we can see that the
lines are roughly parallel over all gestational ages (Figure A.2). In the model with a time
interaction, the P-value for the interaction term can provide a statistical test of the
proportional hazards assumption; high P-values indicate that the hazards are not significantly
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different from each other. The P-value for the interaction term in our model was 0.30
indicating that we would accept the null hypotheses of equivalent hazards.
Lastly, we ran a proportional hazards regression model using a robust variance estimator
to account for our repeated measures study design. The hazard ratio for malaria was
elevated but not statistically significant [hazard ratio=1.7, 95% confidence interval (0.8, 3.4].
A 1 degree of freedom test of the malaria variable also indicated that malaria was not a
significant predictor of time to development of IUGR in the proportional hazards regression
model (p=0.16)
Figure A.1. Kaplan Meier curves comparing malaria positive and negative women.
(Dotted line=malaria positive, solid line=malaria negative)
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Figure A.2. Log-negative log survival curves comparing malaria positive and negative
women
(Dotted line=malaria positive, solid line=malaria negative)
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APPENDIX B: 
AN OVERVIEW OF MIXED EFFECT MODELS
In longitudinal studies, the observations collected on a single subject over time (often
called nested within a subject) are highly correlated. Mixed effect models account for the
correlation in longitudinal studies by allowing the regression coefficients to differ between
subjects.133 The simplest form of a mixed effect model is one in which only the intercept can
vary between subjects; more complex forms also allow the time (or slope) variable to vary. In
this type of analysis, the unexplained variance in the outcome variable is divided into
different components; one for the random intercept and another for the random slope.
Mixed effect model techniques are especially relevant in fetal growth analysis as they can
be used to model heteroscadastic data, or data in which the variance in the outcome variable
changes over time (in this case, variance increases with gestational age). Other advantages
of mixed effect models is that they can accommodate un-equal spacing of time intervals, use
all data that is available on a subject (i.e., will not eliminate the whole case for some missing
data), and allows for the modeling of time-varying covariates such as malaria infection or
anemia status.
If ijY denotes the estimated fetal weight for fetus i at measurement occasion j and ijT
denotes the gestational age for fetus i at measurement occasion j, then the level 1 and level
2 mixed models can be expressed as:
Level 1: Visit level equation (within-person)
2
0 1 where ~ (0, )ijij j j ij ij ij rY T r r N  = + +  
Level 2: Women level equations (between-person)
0 00 0 (random intercept)j j  µ= +  
1 10 1 (random slope)j j  µ= +  
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, and 00 01and  are the average of the
women level intercepts and slopes, respectively. 0 jµ represents the between-women
variation in intercepts and is ~ N(0, 2
0 j
 ) and 1 jµ represents the between-women variation
in slopes and is ~ N(0, 2
1 j
 ). The covariance between the random slopes and random
intercepts is denoted as
jj 10 ,
 .
Substituting the Level 2 equations into the Level 1 equation yields the mixed effects
model:
00 10 1( ) ( )ij oj j ij ijY T r µ  µ= + + + + or alternatively as
00 10 1( ) ( )ij ij oj j ij ijY T T r  µ µ= + + + +
The above example demonstrates a situation in which there are both random intercepts
and slopes. At times, only one of these may be necessary or of interest to the research
question. In those situations, the other component would simply be interpreted as a fixed
effect. As well, additional level 1 and level 2 covariates can be added to the model as main
exposures or confounding factors.
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APPENDIX C: 
LINEAR MIXED EFFECT MODELS FOR MEAN ESTIMATED FETAL WEIGHT BY
MALARIA AND NUTRITIONAL STATUS
This appendix contains the results of a secondary analysis to assess the effects of malaria
and maternal under-nutrition on mean fetal weight. These data were derived from linear
mixed effect models fitted to data from 758 follow-up visits that occurred after 22 weeks.
Gestational age was modeled as rounded weeks based on the ultrasound derived date. All
final models contained a random intercept term and time was modeled using a quadratic and
cubic polynomial. In the tables below, a negative value for the beta coefficient indicates a
lower fetal weight in the exposed group, whereas a positive value for the beta coefficient
indicates higher fetal weight in the unexposed group.
In general, the direction of the associations for mean fetal weight were similar to the risk
ratio (RR) results demonstrated in Chapter 3, such that exposures with a RR value above
one correspond to a decreased fetal weight in grams. The pattern of effect measure
modification by maternal under-nutrition was also evident in the mean fetal weight data.
Fetuses exposed to malaria were significantly smaller among women with low
anthropometric measures compared to women with normal values.
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Table C.1. Beta coefficients and 95% confidence intervals (CI) for mean fetal weight by
sociodemographic and pregnancy characteristics, Kinshasa, Democratic Republic of
Congo, 2005-2006
Beta
coefficient*
95% CI
Maternal age (years)
18-24 -59 -108,-10
25-29 Ref Ref
 30 -32 -79, 15
Socioeconomic status
High 24 -34, 82
Low Ref Ref
Gravida
1-2 -27 -67, 13
 3 Ref Ref
Fetal gender
Male 34 -6, 73
Female Ref Ref
Treated in previous month
Yes 34 11, 57
No Ref Ref
Hematocrit at visit
< 30 37 -26, 99
 30 Ref Ref
* Unadjusted. Model included 758 study visits. Difference in mean fetal weight for a fetus exposed to
the covariate of interest. Positive EFW values indicate higher attained weight among the exposed
while negative values indicated lower fetal weight.
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Table C.2. Beta coefficients and 95% confidence intervals (CI) for mean fetal weight by incident and cumulative malaria
infection, Kinshasa, Democratic Republic of Congo, 2005-2006
Beta
coefficient†
95% CI Beta
coefficient‡
95% CI Beta
coefficient§
95% CI
Malaria parasitemia at visit
Positive -5 -43, 33 -5 -42, 33 7 -34, 48
Negative Ref Ref Ref Ref Ref Ref
Cumulative malaria
parasitemia up to visit
0 Ref Ref Ref Ref Ref Ref
1 13 -22, 48 16 -19, 50 27 -8, 62
2 31 -22, 84 33 -20, 86 27 -32, 86
3 -45 -128, 38 -42 -125, 41 -74 -170, 22
Cumulative malaria
parasitemia up to visit
2 positive -8 -54, 38 8 -38, 53 -8 -59, 43
<2 positive Ref Ref Ref Ref Ref Ref
3 positive
<3 positive
-63
Ref
-141, 15
Ref
-61
Ref
-139, 17
Ref
-92
Ref
-185, 1
Ref
† Unadjusted. Model included 758 study visits.
‡ Adjusted for age. Model included 758 study visits.
§ Adjusted for age and weight gain. Model included 588 visits with complete data for weight gain.
Difference in mean fetal weight for a fetus exposed to the covariate of interest. Positive EFW values indicate higher attained weight among the
exposed while negative values indicated lower fetal weight.
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Table C.3. Beta coefficients and 95% confidence intervals (CI) for mean fetal weight by maternal anthropometric indicators,
Kinshasa, Democratic Republic of Congo, 2005-2006
Beta
coefficient†
95% CI Beta
coefficient‡
95% CI Beta
coefficient§
95% CI
Time-independent variables
Baseline BMI
<19.8 kg/m2
19.8 kg/m2
-48
Ref
-110, 14
Ref
-33
Ref
-96, 30
Ref
-9
Ref
-71, 53
Ref
Short stature
<150 cm
150 cm
-79
Ref
-188, 30
Ref
-68
Ref
-177, 40
Ref
-57
Ref
-167, 52
Ref
Time-dependent variables
MUAC change per month #
Baseline BMI <19.8 kg/m2
Baseline BMI 19.8 kg/m2
-34
6
-104, 36
-20, 32
-34
6
-104, 36
-20, 31
-37
20
-104, 30
-6, 47
Maternal weight gain per month**
Baseline BMI <19.8 kg/m2
Baseline BMI 19.8 kg/m2
--
--
--
--
--
--
--
--
-68
-22
-140, 3
-49, 5
† Unadjusted. Model included 758 study visits.
‡ Adjusted for age. Model included 758 study visits.
§ Adjusted for age. Model included 588 visits with complete data for weight gain.
# Comparing MUAC change in the previous month of < 0 cm vs.  0 cm.
**Comparing maternal weight gain in the previous month of < 1.5 kg per month vs.  1.5 kg per month.
Difference in mean fetal weight for a fetus exposed to the covariate of interest. Positive EFW values indicate higher attained weight among the
exposed while negative values indicated lower fetal weight.
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Table C.4. Beta coefficients and 95% confidence intervals (CI) for mean fetal weight by malaria status, stratified by maternal
anthropometrics, Kinshasa, Democratic Republic of Congo, 2005-2006
Beta
coefficient*
95% CI Beta
coefficient†
95% CI Beta
coefficient‡
95% CI
Malaria parasitemia at visit
(Positive vs. negative)
Baseline BMI <19.8 kg/m2
Baseline BMI 19.8 kg/m2
-70
6
-172, 32
-34, 46
-69
5
-173, 35
-35, 45
-95
27
-211, 21
-17, 71
Height <150 cm
Height 150 cm
-132
-2
-382, 118
-40, 36
-124
-2
-374, 125
-40, 36
-146
16
-386, 94
-26, 58
MUAC gain <0 cm in past month
MUAC gain 0 cm in past month
-19
20
-80, 42
-35, 75
-19
19
-80, 41
-36, 74
-17
40
-79, 44
-16, 95
Weight gain <1.5 kg in past month
Weight gain 1.5 kg in past month
--
--
--
--
--
--
--
--
-39
-10
-29, 107
-61, 41
Cumulative malaria parasitemia
( 2 positive vs. < 2 positive)
Baseline BMI <19.8 kg/m2
Baseline BMI 19.8 kg/m2
-138
25
-272, -4
-24, 73
-135
25
-268, -1
-24, 73
-117
7
-272, 39
-47, 62
Height <150 cm
Height 150 cm
-49
12
-246, 148
-35, 59
-66
13
-262, 131
-34, 60
-70
1
-264, 124
-53, 54
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Table C.4., continued
Beta
coefficient*
95% CI Beta
coefficient†
95% CI Beta
coefficient‡
95% CI
MUAC gain <0 cm in past month
MUAC gain 0 cm in past month
-5
12
-68, 58
-45, 69
-6
14
-69, 56
-42, 71
7
-27
-61, 75
-90, 36
Weight gain <1.5 kg in past month
Weight gain 1.5 kg in past month
--
--
--
--
--
--
--
--
0
-13
-71, 71
-73, 47
* Unadjusted. Model included 758 study visits and 76 episodes of IUGR.
† Adjusted for age. Model included 758 study visits and 76 episodes of IUGR.
‡ Adjusted for age. Model included 588 visits with complete data for weight gain and 66 episodes of IUGR.
Difference in mean fetal weight for a fetus exposed to the covariate of interest. Positive EFW values indicate higher attained weight among the
exposed while negative values indicated lower fetal weight.
Note: Mean fetal weight pairs highlighted in bold indicate a significant P-value for the interaction term between malaria and the anthropometric
indicator (P-value <0.15).
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APPENDIX D: 
INFLUENCE DIAGNOSTICS FOR SPECIFIC AIM 2
The following influence statistics were used to identify fetuses that influenced the
estimates of the fixed effects and/or precision of the variance and covariance portions of the
model.
Restricted likelihood distance: A global, summary measure of the influence of removing an
observation jointly on all parameters. Calculated as twice the difference between the
(restricted) log-likelihood evaluated at the full-data set and the reduced-data set.
PRESS statistic (Prediction Sum of Squares Statistic): Measures the change in the
predicted value of the response ( )ijY variable caused by removal of an observation.
Calculated as the sums of squares of the prediction residuals (calculated as the difference
between the predicted response variable including the observation and the predicted
response variable after removing the observation).
Cook’s D: Measures the change in the parameter estimates caused by removal of an
observation.
MDFFITS: Measures the change in parameter estimates due to removal of an observation
(Closely related to Cook’s D).
COVRATIO and COVTRACE: Measures the effect on the precision of the covariance
matrix of the parameter estimates due to removal of an observation.
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Table D.1. Influence diagnostics for log transformed estimated fetal weight
INFLUENCE DIAGNOSTICS FOR THE
FIXED EFFECTS
INFLUENCE DIAGNOSTICS FOR THE
RANDOM EFFECTS
Id Number of
Observations
in Level
Restricted
Likelihood
Distance
PRESS
Statistic
Cook's D COVRATIO Cook's D
CovParms
MDFFITS
CovParms
COVRATIO
CovParms
COVTRACE
CovParms
7100 6 0.0080 0.01472 0.00029 1.0304 0.00764 0.00746 1.0806 0.0784
7103 5 0.0648 0.04476 0.00291 1.0221 0.05971 0.06090 1.0308 0.0311
7108 6 0.0147 0.04414 0.00443 1.0214 0.00568 0.00557 1.0570 0.0560
7114 6 0.0092 0.01379 0.00077 1.0298 0.00740 0.00724 1.0814 0.0791
7118 5 0.0125 0.01947 0.00368 1.0224 0.00602 0.00594 1.0466 0.0459
7123 5 0.0157 0.00987 0.00144 1.0224 0.01291 0.01267 1.0710 0.0692
7124 5 0.0072 0.02215 0.00142 1.0228 0.00418 0.00411 1.0577 0.0566
7125 5 0.0149 0.01837 0.00255 1.0213 0.00984 0.00967 1.0643 0.0628
7127 5 0.0114 0.01309 0.00334 1.0201 0.00465 0.00456 1.0490 0.0482
7129 4 0.0131 0.02726 0.00337 1.0189 0.00656 0.00648 1.0383 0.0380
7130 5 0.0161 0.00816 0.00336 1.0194 0.00865 0.00850 1.0500 0.0493
7132 5 0.0516 0.07524 0.01288 0.9978 0.02632 0.02707 0.9834 0.0159
7136 5 0.0103 0.02697 0.00207 1.0199 0.00552 0.00546 1.0456 0.0449
7143 5 0.0198 0.04461 0.00637 1.0152 0.00683 0.00676 1.0356 0.0353
7145 6 0.0124 0.01587 0.00121 1.0288 0.01008 0.00988 1.0820 0.0797
7146 6 0.0123 0.03273 0.00235 1.0260 0.00828 0.00815 1.0608 0.0596
7150 5 0.0339 0.02749 0.00943 1.0048 0.01717 0.01746 0.9869 0.0124
7151 5 0.0090 0.00509 0.00006 1.0240 0.00894 0.00879 1.0749 0.0729
7154 6 0.0211 0.00655 0.00280 1.0313 0.01568 0.01536 1.0849 0.0823
7155 6 0.1889 0.03999 0.01706 0.9833 0.12686 0.12924 0.9823 0.0155
7157 6 0.0513 0.04493 0.00514 1.0293 0.04340 0.04388 1.0468 0.0466
7158 6 0.0335 0.03050 0.00896 1.0113 0.01265 0.01268 1.0180 0.0183
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INFLUENCE DIAGNOSTICS FOR THE
FIXED EFFECTS
INFLUENCE DIAGNOSTICS FOR THE
RANDOM EFFECTS
Id Number of
Observations
in Level
Restricted
Likelihood
Distance
PRESS
Statistic
Cook's D COVRATIO Cook's D
CovParms
MDFFITS
CovParms
COVRATIO
CovParms
COVTRACE
CovParms
7159 5 0.0220 0.04062 0.00702 1.0118 0.00810 0.00806 1.0126 0.0128
7163 6 0.0660 0.08653 0.01360 1.0101 0.03887 0.03937 1.0215 0.0224
7171 6 0.0157 0.03277 0.00378 1.0292 0.00730 0.00712 1.0669 0.0655
7174 5 0.0081 0.00592 0.00001 1.0261 0.00815 0.00801 1.0777 0.0756
7179 5 0.0170 0.05201 0.00535 1.0151 0.00661 0.00656 1.0283 0.0281
7181 6 0.0155 0.02295 0.00076 1.0310 0.01481 0.01462 1.0717 0.0701
7189 5 0.0491 0.08151 0.01195 0.9994 0.02337 0.02404 0.9792 0.0202
7192 5 1.2339 0.35792 0.06751 0.8958 0.93784 1.20143 0.6721 0.3583
7195 5 0.0090 0.01946 0.00039 1.0244 0.00835 0.00825 1.0615 0.0603
7196 6 0.0630 0.06414 0.01568 0.9978 0.03465 0.03556 0.9900 0.0092
7204 5 0.0148 0.00980 0.00129 1.0214 0.01240 0.01217 1.0696 0.0679
7205 6 0.0686 0.08849 0.01297 1.0063 0.04293 0.04349 0.9822 0.0171
7207 5 0.0558 0.04347 0.01458 0.9975 0.02996 0.03139 0.9643 0.0348
7211 5 0.0141 0.00288 0.00047 1.0226 0.01338 0.01312 1.0742 0.0722
7214 5 0.0114 0.02741 0.00348 1.0158 0.00412 0.00407 1.0334 0.0331
7215 5 0.0648 0.03343 0.01579 0.9954 0.03787 0.03968 0.9553 0.0439
7217 6 0.0185 0.02582 0.00685 1.0242 0.00549 0.00540 1.0519 0.0510
7218 5 0.0056 0.01117 0.00045 1.0226 0.00457 0.00449 1.0654 0.0639
7221 5 0.0091 0.02758 0.00303 1.0207 0.00294 0.00287 1.0531 0.0521
7224 6 0.0361 0.04557 0.00935 1.0106 0.01868 0.01861 1.0280 0.0281
7228 6 0.1041 0.12847 0.01861 0.9984 0.06532 0.06802 0.9810 0.0175
7236 5 0.0260 0.02730 0.00852 1.0073 0.01086 0.01103 1.0037 0.0042
7237 5 0.0886 0.04090 0.02029 0.9896 0.05422 0.05806 0.9357 0.0635
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INFLUENCE DIAGNOSTICS FOR THE
FIXED EFFECTS
INFLUENCE DIAGNOSTICS FOR THE
RANDOM EFFECTS
Id Number of
Observations
in Level
Restricted
Likelihood
Distance
PRESS
Statistic
Cook's D COVRATIO Cook's D
CovParms
MDFFITS
CovParms
COVRATIO
CovParms
COVTRACE
CovParms
7243 4 0.0080 0.00894 0.00224 1.0194 0.00353 0.00347 1.0507 0.0498
7244 6 0.4435 0.09805 0.02722 0.9544 0.32610 0.36132 0.8663 0.1364
7247 6 0.0179 0.02192 0.00346 1.0292 0.01142 0.01114 1.0760 0.0740
7248 6 0.0515 0.09191 0.01030 1.0129 0.03174 0.03187 1.0111 0.0116
7249 6 0.0662 0.02824 0.01771 0.9998 0.03764 0.03846 0.9967 0.0024
7251 5 0.0072 0.02191 0.00225 1.0197 0.00252 0.00248 1.0521 0.0512
7258 5 0.0070 0.00774 0.00013 1.0245 0.00679 0.00667 1.0735 0.0716
7260 7 0.0188 0.02556 0.00314 1.0328 0.01220 0.01189 1.0855 0.0830
7261 4 0.0191 0.04081 0.00547 1.0087 0.00780 0.00780 1.0056 0.0057
7272 6 0.0134 0.01057 0.00274 1.0234 0.00839 0.00823 1.0684 0.0667
7275 5 0.0608 0.06067 0.01350 0.9954 0.03472 0.03600 0.9559 0.0438
7276 4 0.1497 0.05185 0.00146 1.0242 0.14130 0.14703 1.0180 0.0195
7278 6 0.0407 0.05240 0.01006 1.0071 0.01807 0.01829 1.0077 0.0083
7284 5 0.0102 0.01133 0.00128 1.0252 0.00782 0.00769 1.0726 0.0707
7285 5 0.0097 0.01328 0.00295 1.0209 0.00390 0.00382 1.0511 0.0502
7289 5 0.0496 0.03682 0.00265 1.0168 0.04184 0.04246 1.0165 0.0169
7290 6 0.0098 0.01127 0.00100 1.0269 0.00804 0.00789 1.0771 0.0750
7295 5 0.0239 0.03129 0.00596 1.0128 0.01293 0.01272 1.0394 0.0390
7296 6 0.0142 0.01569 0.00265 1.0311 0.00958 0.00937 1.0805 0.0782
7297 5 0.0135 0.01472 0.00181 1.0220 0.01005 0.00988 1.0683 0.0667
7302 6 0.0135 0.02232 0.00037 1.0305 0.01204 0.01187 1.0713 0.0697
7308 5 0.0147 0.01187 0.00270 1.0223 0.00922 0.00905 1.0627 0.0614
7309 5 0.0162 0.01916 0.00370 1.0178 0.00927 0.00910 1.0538 0.0528
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INFLUENCE DIAGNOSTICS FOR THE
FIXED EFFECTS
INFLUENCE DIAGNOSTICS FOR THE
RANDOM EFFECTS
Id Number of
Observations
in Level
Restricted
Likelihood
Distance
PRESS
Statistic
Cook's D COVRATIO Cook's D
CovParms
MDFFITS
CovParms
COVRATIO
CovParms
COVTRACE
CovParms
7313 5 0.0212 0.01755 0.00655 1.0106 0.01003 0.01001 1.0221 0.0223
7314 5 0.0109 0.01173 0.00165 1.0205 0.00775 0.00761 1.0617 0.0603
7317 6 0.0413 0.09362 0.01051 1.0117 0.01998 0.02006 1.0174 0.0179
7322 5 0.0145 0.02303 0.00444 1.0231 0.00662 0.00654 1.0462 0.0455
7325 4 0.0718 0.04606 0.00472 1.0180 0.05880 0.06011 1.0164 0.0169
7328 5 0.0135 0.00276 0.00013 1.0297 0.01338 0.01312 1.0865 0.0838
7331 6 0.2769 0.05913 0.02046 0.9667 0.19324 0.21657 0.8771 0.1234
7332 5 0.0115 0.02363 0.00265 1.0193 0.00620 0.00611 1.0579 0.0567
7333 6 0.0705 0.04425 0.00672 1.0278 0.05994 0.06108 1.0384 0.0385
7346 4 0.0058 0.01603 0.00119 1.0185 0.00327 0.00322 1.0464 0.0457
7349 5 0.0282 0.04882 0.00787 1.0084 0.01144 0.01147 1.0150 0.0153
7350 5 0.0166 0.00114 0.00056 1.0245 0.01554 0.01523 1.0777 0.0755
7351 5 0.0059 0.01585 0.00109 1.0229 0.00413 0.00406 1.0622 0.0608
7352 6 0.0187 0.03272 0.00572 1.0274 0.00824 0.00802 1.0634 0.0622
7354 5 0.0908 0.06359 0.01903 0.9887 0.05630 0.05937 0.9509 0.0482
7357 2 0.0042 0.00661 0.00135 1.0114 0.00152 0.00149 1.0279 0.0277
7358 6 0.0114 0.02289 0.00147 1.0314 0.00925 0.00906 1.0744 0.0726
7360 5 0.0100 0.01642 0.00330 1.0204 0.00366 0.00358 1.0481 0.0474
7362 5 0.0407 0.06132 0.01061 1.0093 0.01965 0.01981 1.0160 0.0165
7366 5 0.0162 0.00392 0.00180 1.0242 0.01251 0.01228 1.0704 0.0686
7367 4 0.0223 0.02325 0.00031 1.0225 0.02159 0.02167 1.0480 0.0475
7370 5 0.0067 0.01277 0.00118 1.0240 0.00481 0.00471 1.0635 0.0621
7375 5 0.0073 0.01512 0.00180 1.0201 0.00371 0.00364 1.0538 0.0528
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INFLUENCE DIAGNOSTICS FOR THE
FIXED EFFECTS
INFLUENCE DIAGNOSTICS FOR THE
RANDOM EFFECTS
Id Number of
Observations
in Level
Restricted
Likelihood
Distance
PRESS
Statistic
Cook's D COVRATIO Cook's D
CovParms
MDFFITS
CovParms
COVRATIO
CovParms
COVTRACE
CovParms
7380 5 0.0449 0.06817 0.01170 1.0021 0.02127 0.02181 0.9843 0.0152
7383 6 0.0283 0.02110 0.00446 1.0261 0.01973 0.01926 1.0765 0.0745
7386 2 0.0253 0.02105 0.00723 1.0110 0.01223 0.01227 0.9984 0.0010
7387 6 0.0123 0.02657 0.00125 1.0314 0.01003 0.00983 1.0735 0.0717
7389 5 0.0098 0.02529 0.00266 1.0212 0.00387 0.00381 1.0503 0.0494
7390 6 0.3388 0.24526 0.03084 0.9661 0.24901 0.27776 0.9015 0.0967
7391 5 0.0189 0.04640 0.00426 1.0193 0.01045 0.01039 1.0374 0.0371
7394 6 0.0168 0.02703 0.00586 1.0199 0.00521 0.00511 1.0397 0.0392
7395 4 0.0086 0.00184 0.00006 1.0210 0.00853 0.00839 1.0674 0.0658
7396 5 0.0099 0.03243 0.00367 1.0162 0.00244 0.00240 1.0384 0.0379
7397 6 0.1279 0.06556 0.01758 0.9898 0.07879 0.08329 0.9557 0.0431
7400 6 0.0183 0.01101 0.00396 1.0262 0.01009 0.00990 1.0701 0.0684
7403 6 1.1555 0.44762 0.05373 0.9131 0.87581 1.09354 0.7817 0.2207
7404 5 0.0085 0.01616 0.00162 1.0222 0.00522 0.00514 1.0636 0.0622
7407 6 0.0522 0.08065 0.00951 1.0189 0.03467 0.03476 1.0234 0.0238
7410 5 0.0154 0.02155 0.00559 1.0157 0.00495 0.00489 1.0382 0.0378
7412 5 0.0734 0.07220 0.01549 0.9981 0.04283 0.04413 0.9914 0.0075
7413 5 0.0114 0.02384 0.00174 1.0240 0.00726 0.00717 1.0548 0.0539
7415 5 0.0329 0.04260 0.00268 1.0241 0.02669 0.02683 1.0432 0.0430
7419 5 0.0221 0.04056 0.00698 1.0131 0.00762 0.00758 1.0277 0.0277
7420 5 0.0106 0.01014 0.00225 1.0193 0.00648 0.00637 1.0544 0.0534
7423 6 0.0368 0.06890 0.00869 1.0172 0.01871 0.01857 1.0428 0.0427
7424 5 0.0815 0.04306 0.00288 1.0264 0.07698 0.07881 1.0376 0.0380
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INFLUENCE DIAGNOSTICS FOR THE
FIXED EFFECTS
INFLUENCE DIAGNOSTICS FOR THE
RANDOM EFFECTS
Id Number of
Observations
in Level
Restricted
Likelihood
Distance
PRESS
Statistic
Cook's D COVRATIO Cook's D
CovParms
MDFFITS
CovParms
COVRATIO
CovParms
COVTRACE
CovParms
7425 5 0.0175 0.01198 0.00473 1.0184 0.00906 0.00890 1.0524 0.0515
7426 7 0.0435 0.06981 0.01000 1.0136 0.02188 0.02168 1.0413 0.0411
7427 5 0.0211 0.01778 0.00493 1.0254 0.01144 0.01119 1.0638 0.0625
7428 5 0.0149 0.02143 0.00371 1.0239 0.00870 0.00863 1.0482 0.0476
7430 5 0.0464 0.02318 0.01280 1.0008 0.02561 0.02646 0.9825 0.0164
7433 5 0.0430 0.02981 0.01198 1.0010 0.02306 0.02373 0.9860 0.0131
7435 5 0.0118 0.00501 0.00035 1.0259 0.01120 0.01100 1.0792 0.0770
7437 6 0.3676 0.09486 0.04903 0.9584 0.27158 0.30023 0.8913 0.1075
7438 5 0.0175 0.02214 0.00337 1.0225 0.01102 0.01081 1.0647 0.0632
7439 5 0.0984 0.05754 0.00673 1.0194 0.08693 0.08940 1.0112 0.0120
7440 5 0.0084 0.02152 0.00181 1.0264 0.00496 0.00484 1.0664 0.0650
7441 5 0.0194 0.02774 0.00666 1.0189 0.00599 0.00590 1.0404 0.0399
7442 5 0.0135 0.00957 0.00139 1.0282 0.01091 0.01070 1.0789 0.0767
7444 5 0.0187 0.00438 0.00279 1.0205 0.01405 0.01376 1.0631 0.0617
7448 6 0.0337 0.07829 0.00974 1.0121 0.01461 0.01463 1.0237 0.0239
7449 6 0.1075 0.06271 0.01991 0.9902 0.07068 0.07374 0.9466 0.0532
7451 4 0.0086 0.00836 0.00143 1.0196 0.00573 0.00564 1.0564 0.0553
7452 5 0.0573 0.07304 0.01263 1.0054 0.03196 0.03252 1.0095 0.0103
7456 5 0.0175 0.00656 0.00254 1.0210 0.01315 0.01289 1.0652 0.0637
7458 5 0.0712 0.10232 0.01471 0.9977 0.03944 0.04079 0.9744 0.0248
7459 4 0.0445 0.04196 0.01215 0.9990 0.02180 0.02256 0.9753 0.0241
7460 4 0.0112 0.01681 0.00288 1.0164 0.00539 0.00532 1.0471 0.0463
7464 5 0.0149 0.00666 0.00209 1.0324 0.01143 0.01118 1.0821 0.0797
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Id Number of
Observations
in Level
Restricted
Likelihood
Distance
PRESS
Statistic
Cook's D COVRATIO Cook's D
CovParms
MDFFITS
CovParms
COVRATIO
CovParms
COVTRACE
CovParms
7465 5 0.0149 0.02085 0.00288 1.0233 0.00914 0.00897 1.0662 0.0647
7467 5 0.0079 0.00922 0.00126 1.0218 0.00541 0.00532 1.0620 0.0606
7470 5 0.0337 0.03183 0.00864 1.0084 0.01406 0.01420 1.0076 0.0081
7472 6 0.2075 0.06738 0.02030 0.9765 0.14013 0.15333 0.8975 0.1030
7474 5 0.0295 0.03520 0.00199 1.0247 0.02399 0.02411 1.0463 0.0459
7476 7 0.0373 0.06329 0.00538 1.0229 0.02429 0.02431 1.0481 0.0476
7477 7 0.0162 0.01044 0.00017 1.0394 0.01616 0.01572 1.0987 0.0953
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Figure D.1. Influence diagnostics for log transformed estimated fetal weight variable:
effects on the fixed portion of the mixed effects model
Figure D.2. Influence diagnostics for log transformed estimated fetal weight variable:
effects on the random portion of the mixed effects model
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APPENDIX E: 
SENSITIVITY ANALYSIS FOR DEVELOPMENT OF THE FETAL SIZE NOMOGRAM UTILIZING A
DIFFERENT ESTIMATED FETAL WEIGHT FORMULA
Measurement of fetal biometry by ultrasound is the gold standard for estimating the size or
weight of a fetus and is assumed to be more accurate than clinical methods including
palpation or measurement of fundal height. Many researchers have generated algorithms
where log weight is calculated as a polynomial function of various biometric parameters.159 A
recent analysis comparing the accuracy of 25 ultrasound derived EFW algorithms found that
correlation between actual birth weight and predicted birth weight ranged from 0.44 to 0.79,
with mean absolute errors ranging from ± 263 grams to 646 grams (± 7.5% to 18.5%).158
Because fetal weight estimation is an important component of a fetal size nomogram, we
wanted to explore how the use of another EFW algorithm would affect the centile values of
the fetal size nomogram developed for Congo. We re-ran the data analysis and created a
new nomogram based upon EFW calculated using the algorithm proposed by Shepard
which utilizes two biometric parameters, AC and BPD [log(EFW)= -1.7492 + 0.166*BPD +
0.046*AC - 0.002646*BPD*AC].136 This formula has been shown to have low systematic and
random error in the estimation of fetal weight.
Table E.1 displays the 10th, 50th, and 90th centile values for the nomograms utilizing the
Hadlock and Shepard EFW formulas. Generally, the centiles derived from the two algorithms
are quite similar, with the exception of late in gestation when the centiles derived using the
Shepard EFW are increasingly larger than the Hadlock derived values. Unlike the curve
derived from the Hadlock data, the Shepard derived EFW values do not show a leveling off
near term, and hence overestimate the Hadlock values after about 35 weeks gestation.
We also ran a small analysis to assess the accuracy of the EFW measurements against
actual post-term birth weights (Table E.2). The percent difference between the 50th centile
predicted fetal weight and the actual term birth weight at 38, 39 and 40 weeks gestation was
3.7%, 7.1% and 6.9% for the Hadlock EFW algorithm, and 4.8%, 9.1% and 9.9% for the
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Shepard algorithm, respectively. Thus, the Hadlock EFW algorithm provided a better
estimate of fetal weight than the Shepard algorithm in this population.
In conclusion, the centile values of the Congo derived nomogram appear fairly robust to
differing EFW algorithms, except near term when the differences varied by as much as 200
grams. The Hadlock EFW algorithm appears to provide a more accurate estimation of fetal
weight as evidenced by lower percent differences between predicted and actual weight for
infants born at term. Thus, we feel that the nomogram based upon the Hadlock algorithm is
the better choice for presentation.
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Table E.1. Comparison of the predicted 10th, 50th and 90th centiles utilizing the
estimated fetal weight algorithms by Hadlock and Shepard
Using Hadlock
EFW formula27
Using the Shepard
EFW formula136
GA
weeks 10th 50th 90th 10th 50th 90th
20 289 315 345 306 338 373
21 347 380 415 362 400 442
22 415 454 497 426 472 523
23 491 539 591 499 554 614
24 578 635 698 580 645 718
25 675 743 819 670 748 836
26 782 864 955 770 863 967
27 900 997 1106 880 990 1112
28 1028 1143 1271 1000 1128 1273
29 1166 1301 1452 1130 1279 1449
30 1313 1471 1647 1269 1442 1639
31 1469 1651 1854 1418 1617 1845
32 1632 1840 2074 1575 1803 2064
33 1801 2036 2302 1740 1999 2296
34 1973 2238 2538 1912 2204 2540
35 2147 2442 2778 2089 2416 2794
36 2321 2647 3019 2270 2634 3055
37 2491 2848 3257 2454 2855 3322
38 2656 3044 3488 2637 3078 3591
39 2813 3230 3709 2820 3299 3860
40 2959 3404 3916 2998 3517 4124
Table E.2. Percent difference between post-natal birth weight measurements and
predicted 50th centile values utilizing the estimated fetal weight algorithms by Hadlock
and Shepard
50th centile
predicted EFW
Percent
difference*
Gestational
age
(weeks)
Hadlock
EFW
Formula
Shepard
EFW
Formula
Post-natal
mean birth
weight
N Hadlock Shepard
38 3044 3078 2930 17 3.7 4.8
39 3230 3299 3000 43 7.1 9.1
40 3404 3517 3169 46 6.9 9.9
Percent difference = (Predicted 50th centile – Postnatal birth weight) / Predicted 10th centile) * 100
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